Page last updated: 2024-08-22

angiotensin ii and Disease Exacerbation

angiotensin ii has been researched along with Disease Exacerbation in 282 studies

Research

Studies (282)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	20 (7.09)	18.2507
2000's	112 (39.72)	29.6817
2010's	127 (45.04)	24.3611
2020's	23 (8.16)	2.80

Authors

Authors	Studies
Assi, R; Caulk, AW; He, C; Humphrey, JD; Jiang, B; Li, G; Lovoulos, CJ; Murtada, SI; Qin, L; Ren, P; Schwartz, MA; Tellides, G; Wang, M	1
Geng, M; Jiang, X; Liu, W; Tan, Z; Xin, Y	1
Jiang, C; Kong, W; Li, X; Lian, G; Liu, H; Pang, Y; Sun, L; Wang, X; Zhang, L; Zhang, T; Zhang, X; Zhang, Y	1
Li, Q; Wang, F; Wei, X; Zhang, J; Zhang, W	1
Alonso, J; Ballester-Servera, C; Cañes, L; Galán, M; Herraiz-Martínez, A; Hove-Madsen, L; Martí-Pàmies, I; Martínez-González, J; Muniesa, P; Nistal, JF; Osada, J; Rodríguez, C	1
Bushinsky, DA; Buysse, JM; Wesson, DE	1
Nataf, S	1
An, X; Tan, A; Wang, L; Xia, Y; Xie, Y	1
Chen, Z; Li, H; Pan, Y; Wang, G; Zhang, H	1
Chen, X; Lio, I; Liu, J; Wang, S; Wei, Z; Xiao, J; Yang, C; Zhang, H	1
Brangsch, J; Buchholz, R; Hamm, B; Karst, U; Klopfleisch, R; Kosch, O; Makowski, MR; Mangarova, DB; Mohtashamdolatshahi, A; Paysen, H; Schnorr, J; Taupitz, M; Wiekhorst, F	1
Baker, AH; Borthwick, G; Boswell, L; Dweck, MR; Gray, GA; Jansen, MA; Kwiecinski, J; Lennen, RJ; Newby, DE	1
Barreto-Chaves, MLM; Senger, N; Takano, APC	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Angus, PW; Burrell, LM; Casey, S; Grace, JA	1
Clarke, MW; Golledge, J; Krishna, SM; Moran, CS; Morton, SK; Moxon, JV; Nsengiyumva, V; Seto, SW	1
Kurashiki, T; Miyake, T; Morishita, R; Nakagami, H; Nishimura, M	1
Chau, LY; Chen, IM; Chen, JW; Chen, YH; Chiang, MT; Hsu, FF; Hsu, YW; Huang, PH; Leu, HB; Liu, FT; Tsai, MS	1
Cai, L; Ding, Y; Fu, W; Li, X; Shi, Z; Tang, H; Xie, T; Zhou, M	1
Chen, L; Chen, X; Hou, Y; Hu, Y; Lin, Y; Lv, X	1
Annapragada, AV; Devkota, L; Ghaghada, KB; LeMaire, SA; Ren, P; Shen, YH; Starosolski, Z; Stupin, IV; Tanifum, EA; Vela, D; Zhang, C	1
Arfsten, H; Bartko, PE; Domenig, O; Goliasch, G; Hengstenberg, C; Hülsmann, M; Mascherbauer, J; Pavo, N; Poglitsch, M; Prausmüller, S; Spinka, G; Strunk, G; Uyanik-Ünal, K; Wurm, R; Zuckermann, A	1
Clancy, P; Crossman, DJ; Emeto, TI; Golledge, J; Jose, R; Krishna, SM; Li, J; Moxon, J; Norman, P; Seto, SW	1
Beanlands, RS; Burns, KD; Croteau, E; DaSilva, JN; deKemp, RA; Hadizad, T; Ismail, B	1
Bialkowska, AB; Gao, X; Gu, X; Guo, Y; He, JC; Jain, MK; Mallipattu, SK; Mei, C; Miller, T; Pace, J; Revelo, MP; Yang, VW	1
Coletta, RD; de Oliveira, CE; Hinsley, EE; Hunt, S; Lambert, DW	1
Armeni, A; Cerantonio, A; Fuiano, G; Simeoni, M; Summaria, C	1
Bu, J; Gao, J; Huang, C; Huang, G; Shen, W; Sun, M; Wei, T; Wu, J	1
Aslanidou, L; Fraga-Silva, RA; Piersigilli, A; Segers, P; Sordet-Dessimoz, J; Stampanoni, MFM; Stergiopulos, N; Trachet, B; Villanueva-Perez, P	1
Baudrie, V; Bonnin, P; Camerer, E; Chipont, A; Guyonnet, L; Hardy, L; Lazareth, H; Lenoir, O; Luque, Y; Mesnard, L; Placier, S; Robin, B; Rondeau, E; Souyri, M; Tharaux, PL; Vandermeersch, S; Xu-Dubois, YC	1
Bakoyiannis, C; Damaskos, C; Georgopoulos, S; Liakakos, T; Moris, D; Patelis, N; Perrea, D; Schizas, D	1
He, B; He, W; Hu, H; Jiang, H; Liu, S; Lu, Z; Luo, D; Ma, R; Qin, Z; Xie, J; Yu, X	1
Chen, R; Jiang, Y; Lu, H; Su, Z; Wu, Y; Zhou, S; Zong, G	1
Kraut, JA; Madias, NE	1
Dalman, RL; Iida, Y; Miyata, M; Xu, B; Xuan, H	1
Chen, J; Deng, P; Ding, X; Huang, X; Ren, L; Wang, K; Wang, S; Wu, C; Wu, J; Xia, J; Ye, P; Yue, Z; Zhang, A	1
Bäcklund, A; Boon, RA; Busch, A; Chernogubova, E; Dacken, B; Dueck, A; Eckstein, HH; Eken, SM; Engelhardt, S; Eriksson, P; Hofmann, P; Jin, H; Karlsson, J; Lao, S; Li, DY; Liu, S; Maegdefessel, L; Pelisek, J; Ramanujam, D; Roy, J; Sennblad, B; Spin, JM; Tsao, PS	1
Adelsperger, AR; Craig, BA; Goergen, CJ; Green, LA; Ibriga, HS; Murphy, MP; Phillips, EH	1
Chen, S; Duan, G; Jin, Y; Ren, J; Xi, Y; Yang, H; Zhang, C; Zhang, R; Zhou, G	1
Anguiano, L; Clotet-Freixas, S; Gimeno, J; Konvalinka, A; Palau, V; Pascual, J; Riera, M; Soler, MJ	1
Agarwal, H; Barthwal, MK; Reddy, SS	1
Chen, Q; Nie, MX; Zhao, QM	1
Llinas, MT; Martinez, CM; Moreno, JM; Oltra, L; Reverte, V; Salazar, FJ; Tapia, A	1
Armesilla, ÁL; Jiménez-Borreguero, LJ; López-Maderuelo, MD; Lozano-Vidal, N; Martínez-Martínez, S; Redondo, JM	1
Egom, EE; Jansen, HJ; Kaur, J; Kirkby, AW; Liu, Y; Mackasey, M; Moghtadaei, M; Rafferty, SA; Rose, RA; Tuomi, JM	1
Cao, R; Qi, B; Wang, Y; Yang, W	1
Wei, W; Wu, HX; Xu, ZW; Yan, SX; Zhang, Y	1
Adams, LC; Botnar, RM; Brangsch, J; Buchholz, R; Hamm, B; Karst, U; Kaufmann, JO; Makowski, MR; Onthank, DC; Reimann, C; Robinson, SP; Thöne-Reineke, C	1
Andersen, ND; Cavanaugh, NB; Dyle, MC; Gensicke, NM; Huang, T; Qian, L; Turek, JW	1
Kellems, RE; Liu, H; Luo, R; Peng, Z; Tao, L; Wang, W; Xia, Y; Xie, T; Zhang, W	1
Andia, ME; Bakewell, R; Botnar, RM; Lacerda, S; Lavin, B; Lorrio, S; Phinikaridou, A; Rashid, I; Smith, A	1
Hirata, Y; Kitagawa, T; Kurobe, H; Matsuoka, Y; Maxfield, MW; Sata, M; Sugasawa, N	1
Fu, XM; Narita, Y; Oshima, H; Ueda, Y; Usui, A; Yamawaki-Ogata, A	1
Bleeker, N; de Vries, CJ; de Waard, V; Girigorie, AF; Hamers, AA; Hibender, S; Hoogenboezem, M; Marinkovic, G; Stap, J; van Broekhoven, A; van Buul, JD	1
Guo, Q; Sagar, SK; Yi, R; Zhang, C	1
Higashimori, M; Ikeya, Y; Ishii, R; Kaneko, M; Komuro, I; Mano, T; Miwa, T; Ohtani, T; Omori, Y; Saito, Y; Sakata, Y; Takeda, Y; Tamaki, S; Tsukamoto, Y; Yamamoto, K	1
Hazama, A; Katsuda, S; Kojima, I; Miyashita, H; Miyawaki, Y; Shimada, K; Shiogai, Y	1
Ishii, K; Kurauchi, Y; Mori, A; Nakahara, T; Sakamoto, K	1
Chien, WM; Chin, MT; Liu, Y; Luchtel, DL; Medvedev, IO; Rosenfeld, ME; Weldy, CS	1
Liu, BC; Liu, J; Lv, LL; Ma, KL; Ni, J; Ruan, XZ; Wang, CX; Wu, Y; Zhang, Y	1
Ayuzawa, N; Fujita, T; Ishizawa, K; Kawarazaki, W; Nagase, M; Takeuchi, M; Ueda, K; Yoshida, S	1
Chen, X; Ding, G; Liang, W; Liu, Y; Ren, Z; Singhal, PC; Yang, Q; Zha, D	1
ap Rhys, CM; Bedja, D; Calderon, JF; Chen, Y; Cooke, SK; Dietz, HC; Gallo, EM; Gerber, EE; Habashi, JP; Huso, DL; Judge, DP; Kent, KC; Lindsay, ME; Loch, DC; Myers, L; Norris, RA; Parker, SJ; Rouf, R; Sauls, K; van Erp, C	1
Ikeda, A; Maesawa, C; Masuda, T; Mizugai, H; Nishinari, Y; Nishiya, M; Oikawa, H; Oikawa, K; Takikawa, Y; Tatemichi, Y	1
Chen, XL; Guo, AB; Huang, MM; Sun, JF; Yin, ZY	1
Cassis, LA; Daugherty, A; Thatcher, S; Wu, C; Zhang, X	1
Hart, A; Ibrahim, HN; Jackson, S; Kasiske, BL; Matas, AJ; Mauer, MS; Najafian, B; Spong, R	1
Bao, C; Cao, B; Cao, H; Chen, Y; Diao, H; Gao, GF; Gao, H; Guo, D; Guo, J; Hu, X; Huang, F; Jiang, C; Li, D; Li, H; Li, L; Liu, J; Liu, Q; Liu, S; Liu, X; Pan, J; Penninger, JM; Qian, G; Sheng, M; Tan, S; Wang, W; Wu, W; Wu, Y; Xiao, H; Xu, Y; Yang, J; Yang, S; Ye, Y; Zeng, M; Zhang, S; Zhao, M; Zhao, X; Zhao, Y; Zheng, S; Zhou, H; Zhu, J; Zou, Z	1
Jang, HS; Kim, JI; Noh, M; Park, KM; Rhee, MH	1
Dai, Z; He, H; Huang, C; Meng, Y; Tang, Y; Wang, X; Xiao, J; Yu, S; Zhao, Q	1
Bavaria, JE; Branchetti, E; Ferrari, G; Gorman, JH; Gorman, RC; Grau, JB; Lai, EK; Poggio, P; Sacks, MS	1
Cao, W; Hou, FF; Jia, N; Liang, M; Liu, Y; Nie, J; Tian, JW; Wang, GB; Wang, J; Xu, J; Zhang, Z; Zhou, ZM	1
Guo, T; Hao, P; Kong, J; Li, D; Meng, X; Yang, J; Zhang, C; Zhang, K; Zhang, M; Zhang, Y	1
Fujii, K; Fujiwara, R; Kitayoshi, M; Kuniyasu, H; Luo, Y; Ohmori, H; Sasaki, T; Sato, S; Tanabe, E; Zhou, L	1
Liu, B; Wang, G; Wang, J	1
Ailawadi, G; Bhamidipati, CM; Hajzus, VA; Meher, AK; Mehta, GS; Owens, GK; Salmon, M; Su, G; Upchurch, GR; Whatling, CA	1
Cheng, J; Garg, V; Hans, CP; Koenig, SN; Kuivaniemi, HS	1
Biros, E; Clancy, P; Golledge, J; Jose, RJ; Krishna, SM; Moran, CS; Seto, SW; Wang, Y	1
Re, RN	3
de Roo, M; Golestani, R; Hilgerink, K; Jung, JJ; Liu, C; Nie, L; Razavian, M; Robinson, SP; Sadeghi, MM; Ye, Y; Zhang, J	1
Aboud, O; Biedermann, J; Gentleman, SM; Griffin, WS; Mrak, RE; Palmer, QD; Zawada, WM	1
Andrés, V; Blanco-Colio, LM; Burillo, E; Calvo, E; Egido, J; Esteban, M; Jorge, I; Laustsen, J; Lindholt, JS; Lopez, JA; Martin-Ventura, JL; Martinez-Pinna, R; Meilhac, O; Michel, JB; Molina-Sánchez, P; Ramos-Mozo, P; Tarin, C; Torres-Fonseca, MM; Vazquéz, J; Vega de Ceniga, M	1
Červenka, L; Husková, Z; Melenovský, V; Nishiyama, A; Sadowski, J; Škaroupková, P	1
Eltzschig, HK; Grenz, A; Jin, J; Kellems, RE; Luo, R; Tao, L; Wu, H; Xia, Y; Zhang, W; Zhang, Y; Zhao, C	1
Ask, K; Carlisle, RE; Cruz, GL; Dickhout, JG; Lu, C; Mohammed-Ali, Z; Werner, KE	1
Cheng, JX; Goergen, CJ; Phillips, EH; Schroeder, HD; Wilson, KE; Yrineo, AA	1
Al-Omran, M; Dhingra, N; Leong-Poi, H; Lovren, F; Quan, A; Ramadan, A; Singh, KK; Teoh, H; Verma, S; Wheatcroft, MD	1
Basile, DP; Collett, JA; Ivancic, CM; Mehrotra, P; Patel, JB	1
Chodavarapu, H; Lazartigues, E; Pedersen, KB; Porretta, C; Robinson, LK	1
Chen, B; Chen, L; Deb, DK; Li, YC; Liu, SQ; Liu, T; Meliton, A; Shi, Y; Solway, J; Wang, J	1
Cheng, X; Daugherty, A; Fernandes, C; Huang, X; Johnsen, SP; Levy, BD; Liao, M; Libby, P; Lindholt, JS; Liu, CL; Ren, J; Shi, GP; Sukhova, GK; Wang, Y; Wemmelund, H; Zhang, JY; Zhou, Y	1
Egashira, K; Katsuki, S; Koga, J; Matoba, T; Nakano, K; Nakashiro, S; Sunagawa, K; Tokutome, M; Umezu, R	1
Aslanidou, L; Astolfo, A; Fraga-Silva, RA; Piersigilli, A; Segers, P; Sordet-Dessimoz, J; Stampanoni, MF; Stergiopulos, N; Trachet, B	1
Antunes, TT; Callera, GE; He, Y; Ryazanov, AG; Ryazanova, LV; Shrier, A; Stewart, DJ; Touyz, RM; Yogi, A; Zhai, A	1
Aguiló, S; Camacho, M; Dilmé, J; Galán, M; Martínez-González, J; Orriols, M; Rodriguez, C; Rodríguez, JA; Varona, S	1
Alvarez-Prats, A; Baranova, IN; Bocharov, AV; Eggerman, TL; Hu, X; Huang, YG; Mullick, AE; Patterson, AP; Remaley, AT; Souza, AC; Star, RA; Street, JM; Vishnyakova, TG; Wilkins, KJ; Yuen, PS	1
Domińska, K; Kowalska, K; Matysiak-Burzyńska, ZE; Ochędalski, T; Piastowska-Ciesielska, AW; Płuciennik, E	1
Kagami, S; Urushihara, M	1
Bricca, G; Kobeissy, F; Marcelo, P; Nasser, R; Nehme, A; Zibara, K	1
Dokmeci, MR; Ferreira, L; Khademhosseini, A; Leijten, J; Miscuglio, M; Nissan, X; Pitrez, PR; Ribas, J; Rouwkema, J; Zhang, YS	1
Gómez, O; Molina-Holgado, E; Uceda, ER; Vera, ME; Vieitez, P	1
Abraham, NG	1
Glassock, RJ	1
Barrios, C; Batlle, D; Oliva, R; Soler, MJ	1
Higaki, N; Horiuchi, M; Kawajiri, M; Kira, JI; Miki, T; Mogi, M; Ohyagi, Y; Tateishi, T	1
Aoki, M; Fujiwara, Y; Makino, H; Miyake, T; Morishita, R; Nishimura, M; Shiraya, S; Yamakawa, S	1
Dohi, K; Fujimoto, N; Imanaka-Yoshida, K; Ito, M; Kurita, T; Nobori, T; Onishi, K; Takamura, T; Tanigawa, T; Wada, H	1
Qian, A; Qiao, M; Wang, J; Yao, W; Yuan, Y; Zhang, R; Zhang, Y; Zhou, L	1
Ishida, K; Kamata, K; Kobayashi, T; Matsumoto, T; Nakayama, N	1
Budge, H; Fainberg, HP; Gardner, DS; Harvey, E; Sharkey, D; Symonds, ME; Wilson, V	1
Fujimura, T; Fujita, H; Fushida, S; Harada, S; Hirakawa, K; Kayahara, M; Kinami, S; Kinoshita, J; Ninomiya, I; Ohta, T; Yagi, Y; Yashiro, M	1
Chen, WQ; Guo, T; Zhang, C; Zhang, Y; Zhao, YX	1
Hayashi, T; Inoue, N; Jin, D; Katayama, H; Kitaura, Y; Miyazaki, M; Muramatsu, M; Takai, S; Tamai, H	1
Bader, M; Bürgelová, M; Cervenka, L; Dvorák, P; Kramer, HJ; Malý, J; Opocenský, M; Thumová, M; Vanourková, Z; Zelízko, M	1
Fan, YY; Fujisawa, Y; Hase, N; Hitomi, H; Kiyomoto, H; Kobori, H; Kohno, M; Matsuura, J; Nakano, D; Nishiyama, A; Urata, H	1
Ahluwalia, A; Duchene, J; Hodgkinson, CP; Hu, Y; Kiechl, S; Laxton, RC; Leung, KY; López-Otín, C; Scotland, RS; Simpson, IA; Smith, K; Willeit, J; Xiao, Q; Xu, Q; Ye, S; Zhang, F; Zhang, Z	1
Kagami, S; Kawachi, H; Kinoshita, Y; Kitamura, A; Kondo, S; Matsuura, S; Shimizu, M; Suga, K; Takamatsu, M; Tamaki, T; Urushihara, M; Yoshizumi, M	1
Mallat, Z	1
Basu, R; Chow, FL; Herzenberg, AM; Janzek, E; Kassiri, Z; Liu, GC; Loibner, H; Oudit, GY; Penninger, JM; Scholey, JW; Schuster, M; Zhong, J; Zhou, J	1
Ahluwalia, N; Anderson, TJ; Gerszten, RE; Hardy, GJ; Kristo, F; Lin, AY; Passeri, J; Scherrer-Crosbie, M; Sinha, S	1
Ait-Oufella, H; Bonnin, P; Combadière, C; Herbin, O; Huang, J; Johnson, JL; Mallat, Z; Offenstadt, G; Ramkhelawon, B; Rénia, L; Taleb, S; Tedgui, A; Tharaux, PL; Wang, Y	1
Crowley, SD; Griffiths, R; Kim, HS; Lin, EE; Ruiz, P; Song, YS	1
Chang, EI; Ikonomidis, JS; Jones, JA; Koval, C; Sheats, N; Spinale, FG; Stroud, RE; Zavadzkas, JA	1
Batifoulier-Yiannikouris, F; Cassis, LA; Daugherty, A; Police, SB; Putnam, K; Thatcher, S	1
Dell, KM; Goto, M; Hoxha, N; Osman, R; Wells, RG; Wen, J	1
Casley, D; Gaspari, TA; Tesanovic, S; Vinh, A; Widdop, RE	1
Cohn, JN	1
Choke, E; Cockerill, GW; Dawson, J; Howe, F; Loftus, IM; Thompson, MM; Wilson, WR	1
Ceconi, C; Ferrari, R; Guardigli, G	1
Asagami, T; Dalman, RL; Dua, MM; Miyama, N; Schultz, GM; Sho, E; Sho, M; Yeung, JJ	1
Chen, R; Eisner, C; Hu, X; Huang, Y; Kopp, JB; Leelahavanichkul, A; Mizel, D; Schnermann, J; Star, RA; Wright, EC; Yan, Q; Yuen, PS; Zhou, H	1
Dell, KM; Goto, M; Hoxha, N; Osman, R	1
Fujimura, T; Fushida, S; Harada, S; Hayashi, H; Iseki, S; Kayahara, M; Kitagawa, H; Nakagawara, H; Nakanuma, S; Ninomiya, I; Ohta, T; Okamoto, K; Onishi, I; Tajima, H; Takamura, H; Tani, T; Wakayama, T	1
Baltatu, OC; Guerra, MJ; Labandeira-Garcia, JL; Muñoz, A; Rodríguez-Pallares, J; Valenzuela, R; Villar-Cheda, B	1
Azuma, J; Barr, KN; Connolly, AJ; Dalman, RL; Goergen, CJ; Gogineni, A; Greve, JM; Grewall, A; Kallop, DY; Magdefessel, L; Taylor, CA; Tsao, PS; Weimer, RM	1
Alenina, N; Bader, M; Bürgelová, M; Cervenka, L; Husková, Z; Kramer, HJ; Malý, J; Mrázová, I; Netuka, I; Opočenský, M; Rakušan, D; Santos, RA; Skaroupková, P; Vaněčková, I; Vaňourková, Z	1
Abadir, PM	1
Ichihara, A; Itoh, H; Kinouchi, K; Kurauchi-Mito, A; Murohashi-Bokuda, K; Narita, T; Nishiyama, A; Ohshima, Y; Ryuzaki, M; Sakoda, M	1
Huang, LY; Su, S; Wang, TC; Yang, MC; Yeh, HL	1
Cha, RH; Jung, ES; Kim, S; Kim, SM; Kim, YS; Lim, CS; Oh, YK	1
Fujimura, T; Fushida, S; Hayashi, H; Kayahara, M; Kitagawa, H; Nakagawara, H; Nakanuma, S; Ohnishi, I; Ohta, T; Okamoto, K; Tajima, H; Takamura, H; Tani, T	1
Fukuda, D; Hirata, Y; Sata, M	1
Kim, HJ; Rodríguez-Iturbe, B; Sato, T; Vaziri, ND	1
Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Namisaki, T; Noguchi, R; Shirai, Y; Tsujimoto, T; Yanase, K; Yoshii, J; Yoshiji, H	1
Aziz, H; Bedja, D; Chen, Y; Dietz, HC; Doyle, JJ; Habashi, JP; Holm, TM; Judge, DP; Modiri, AN; Schoenhoff, F	1
Bergeron, A; Bond, JE; Bowers, EV; Kuang, A; Levinson, H; Selim, MA; Thurlow, P	1
Cassis, LA; Daugherty, A; Lu, H	1
Nishida, M	1
Nordquist, L; Palm, F	1
Coffman, TM; Crowley, SD; Griffiths, R; Herrera, M; Ruiz, P; Zhang, J	1
Eguchi, S; Fujigaki, Y; Hishida, A; Suzuki, H; Yamamoto, T	1
Blackburn, MR; Dai, Y; Kellems, RE; Ning, C; Sun, H; Tao, L; Wang, W; Xia, Y; Yu, H; Zhang, W; Zhang, Y	1
Kagami, S	1
Azuma, J; Chin, JT; Dalman, RL; Deng, A; Leeper, NJ; Maegdefessel, L; McConnell, MV; Merk, DR; Raaz, U; Raiesdana, A; Schoelmerich, AM; Spin, JM; Toh, R; Tsao, PS	1
Bendall, JK; Carter, EE; Channon, KM; Crabtree, MJ; Douglas, G; Hale, AB; Tatham, AL	1
Basile, DP; Beal, AG; Friedrich, J; Leonard, EC; Schleuter, D	1
Aono, J; Higaki, J; Horiuchi, M; Inoue, K; Iwai, M; Nagai, T; Nishimura, K; Ogimoto, A; Okayama, H; Suzuki, J	1
Brittian, KR; Cai, L; Chen, Q; Li, X; McClain, CJ; Prabhu, SD; Tan, Y; Yin, X; Zhou, Z	1
Golledge, J; Krishna, SM; Moxon, JV; Norman, PE; Rush, C; Seto, SW; Walker, PJ	1
Bailey, W; Boyanovsky, BB; Dixon, L; Shridas, P; Webb, NR	1
Gitlin, JM; Loftin, CD; Mukherjee, K	1
Bidani, AK; Griffin, KA; Loutzenhiser, R; Polichnowski, AJ	1
Dalman, RL; Fujimura, N; Glover, KJ; Hu, X; Iida, Y; Schultz, JR; Tanaka, H; Turner, CR; Wang, W; Xu, B; Xuan, H	1
Aihara, Y; Douhara, A; Fukui, H; Kaji, K; Kawaratani, H; Moriya, K; Namisaki, T; Noguchi, R; Shirai, Y; Yoshiji, H	1
Benigni, A; Donadoni, C; Fassi, A; Gagliardini, E; Lepre, MS; Remuzzi, A; Remuzzi, G; Sangalli, F	1
Angelini, A; Calvani, M; Dalla Libera, L; Della Barbera, M; Dona, M; Gobbo, V; Mosconi, L; Peluso, G; Ravara, B; Sandri, M; Vescovo, G	1
Inagaki, K; Iwanaga, Y; Kihara, Y; Mochly-Rosen, D; Onozawa, Y; Sarai, N; Takenaka, H	1
Salahudeen, AK	1
Klahr, S; Morrissey, J	2
Luño, J; Ruilope, LM	1
Araujo, RC; Bader, M; Borges, JC; Gomes, MA; Leite, KM; Lomez, ES; Pesquero, JB; Pesquero, JL; Silva, JA	1
Eisner, GM; Felder, RA; Jose, PA	1
Scholey, JW	1
Burcklé, C; Nguyen, G; Sraer, JD	1
Alebiosu, CO	1
Isono, T; Kinoshita, M; Matsumoto, T; Ohnishi, M; Tsutamoto, T; Wada, A	1
Chudek, J; Kokot, F; Wiecek, A	1
Mogyorósi, A; Sonkodi, S	1
Ivanoviene, L; Lesauskaite, V; Valanciūte, A	1
Egashira, K; Hayashidani, S; Ikeuchi, M; Matsusaka, H; Shiomi, T; Suematsu, N; Takeshita, A; Tsutsui, H; Wen, J	1
Bendall, JK; Byrne, JA; Cave, AC; Gove, C; Grieve, DJ; Lambeth, JD; Li, JM; Shah, AM	1
Ichijo, H; Iwao, H; Izumi, Y; Izumiya, Y; Kim, S; Matsuzawa, A; Yoshida, K; Yoshiyama, M	1
Funatsu, H; Yamashita, H	1
Remuzzi, G; Schieppati, A	2
Agozzino, L; Berrino, L; Cascino, A; Cipollaro, M; Cotrufo, M; De Feo, M; Esposito, F; Esposito, S; Forte, A; Galderisi, U; Quarto, C; Renzulli, A; Rossi, F	1
Centracchio, J; Dworkin, LD; Esparza, A; Gong, R; Rifai, A; Tolbert, E; Yano, N; Zanabli, AR	1
Egashira, K; Hiasa, K; Inoue, S; Ishibashi, M; Kitamoto, S; Ni, W; Nishida, K; Takeshita, A; Usui, M; Zhao, Q	1
Herrera-Acosta, J; Johnson, RJ; Long, DA; Price, KL	1
Granger, DN; Petnehazy, T; Vowinkel, T	1
Alamartine, E	1
Jabs, K; Kon, V	1
Blanco, J; Egido, J; Esteban, V; Kretzler, M; Lorenzo, O; Mezzano, S; Ruiz-Ortega, M; Rupérez, M; Sugaya, T; Suzuki, Y	1
Funatsu, H; Hori, S; Mimura, T; Noma, H; Sakata, K; Yamashita, H	1
Barger, PM; Coker, M; Flesch, M; Li, X; Mann, DL; Sekiguchi, K; Sivasubramanian, N	1
Blankesteijn, WM; Bornstein, P; Cleutjens, JP; Crijns, HJ; Daemen, MJ; Debets, JJ; Duisters, R; Evelo, CT; Heymans, S; Janssen, BJ; Pinto, YM; Pokharel, S; Porter, JG; Schroen, B; Sharma, U; Smits, JF; van Leeuwen, RE	1
Fujita, M; Hirata, A; Hori, M; Kitakaze, M; Liao, Y; Minamino, T; Nagamachi, Y; Nakatani, T; Ogawa, S; Okada, K; Ozawa, K; Takashima, S; Tomoike, H; Tsukamoto, O; Tsukamoto, Y; Yutani, C	1
Monhart, V	1
Dzau, VJ; McMurray, JJ; Pfeffer, MA; Swedberg, K	1
Hiilesmaa, VK; Immonen, IJ; Kaaja, RJ; Loukovaara, S; Nicholls, G; Yandle, TG	1
Furihata, M; Kakinuma, Y; Karashima, T; Kudo, Y; Mori, Y; Morimoto, N; Sato, T; Shuin, T; Sugiura, T	1
Itakura, A; Ito, T; Kikkawa, F; Kobayashi, H; Mitsui, T; Mizutani, S; Nomura, M; Nomura, S; Suzuki, M	1
Golledge, J; Karan, M; Ketheesan, N; McCann, M; Moran, CS; Norman, P	1
Deschamps, AM; Spinale, FG	1
Averill, DB; Brosnihan, KB; Ferrario, CM; Schiffrin, EL; Smith, RD; Yokoyama, H	1
Wolf, G	4
Goens, MB; Lund, AK; Nuñez, BA; Walker, MK	1
Arimoto, T; Konta, T; Koyama, Y; Kubota, I; Niizeki, T; Shishido, T; Takahashi, H; Takeishi, Y	1
Imaizumi, T; Jinnouchi, Y; Matsui, T; Nakamura, K; Nakamura, Y; Takenaka, K; Yamagishi, S	1
Jin, D; Kondo, K; Miyazaki, M; Muramatsu, M; Okamoto, Y; Takai, S; Tanigawa, N	1
Kida, Y	1
Altieri, PI; Crespo, MJ; Escobales, N	1
Gaedeke, J; Neumayer, HH; Peters, H	1
Hishida, A; Ikegaya, N	1
Fukuda, D; Sata, M	1
Enomoto, A; Konda, T; Takahara, A; Yamamoto, H	1
Fuster, V; Levy, AP; Moreno, PR; Purushothaman, KR; Sirol, M	1
Lopaschuk, GD	1
Khan, F; Kumagai, N; Mahmood, J; Morioka, T; Oite, T; Okada, S	1
Chan, CM; Lau, YK; Wong, KS; Woo, KT	1
Cheunsuchon, B; Parichatikanond, P; Sanpakit, K; Supavekin, S	1
Lim, H; Zhu, YZ	1
Agrawal, S; Dharmani, P; Khan, F; Pandirikkal, V; Sharma, RK; Tripathi, G	1
Diniz, JS; Pereira, RM; Pinheiro, SV; Santos, RA; Simões e Silva, AC	1
Prabhakar, S; Rosario, RF	1
Savoia, C; Schiffrin, EL	1
Assad-Kottner, C; Jahanyar, J; Koerner, MM; Loebe, M; Noon, GP; Torre-Amione, G; Youker, KA	1
Ichihara, A; Inagami, T; Itoh, H; Kaneshiro, Y; Nabi, AH; Nakagawa, T; Nishiyama, A; Sakoda, M; Suzuki, F; Takemitsu, T; Uddin, MN	1
Furihata, M; Iguchi, M; Kakinuma, Y; Kudo, Y; Sato, T; Shuin, T; Sugiura, T	1
Fukumoto, H; Furubayashi, K; Ibaraki, T; Jin, D; Katsumata, T; Miyazaki, M; Muramatsu, M; Nishimoto, M; Takai, S	1
Ayabe, N; Babaev, VR; Fazio, S; Fogo, AB; Ichikawa, I; Kon, V; Linton, MF; Motojima, M; Suganuma, E; Zuo, Y	1
Imig, JD; Manhiani, M; Motamed, K; Said, N; Socha, MJ	1
Victor, RG	1
Anandanadesan, R; Arafat, HA; Chipitsyna, G; Gong, Q; Witkiewicz, A; Yeo, CJ	1
Moini, M; Owji, N; Sagheb, MM	1
Geiger, H; Helmut, G	1
Wynn, TA	1
Backx, PH; Crackower, MA; Dawood, F; Kassiri, Z; Liu, PP; Liu, QC; Oudit, GY; Penninger, JM; Scholey, JW; Zhou, J	1
Chiţac, D; Radulian, G; Simion, E; Stoian, M; Stoica, V	1
Deng, BP; Dong, B; Dong, QL; Feng, JB; Li, SY; Liu, B; Liu, CX; Pan, CM; Song, HD; Yang, YP; Yu, QT; Zhang, C; Zhang, MX; Zhang, Y; Zhao, YX; Zhu, L	1
Lee, LK; Lovett, DH; Meyer, TW; Pollock, AS	1
Hiramori, K; Makita, S; Nakamura, M; Yoshida, H	1
Doba, N; Hinohara, S; Kihara, Y; Tomiyama, H; Watanabe, G; Yoshida, H	1
Hymes, J; Ichikawa, I; Matsusaka, T	1
Cazes, M; Cloarec, A; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E	1
Hostetter, TH; Ibrahim, HN; Rosenberg, ME	1
Wolf, G; Ziyadeh, FN	1
Bakris, GL; Tarif, N	1
Fukuda, R; Imura, Y; Matsuo, T; Nagano, H; Nishikawa, K; Noda, M; Ohta, M; Shibouta, Y	1
Yanagisawa, H	1
Fukamizu, A; Goto, K; Kobayashi, T; Maeda, S; Maki, S; Miyauchi, T; Murakami, K; Sakai, S; Sugishita, Y; Sugiyama, F; Takata, Y	1
Nodera, M; Shimoguchi, Y; Umemori, Y; Wada, O; Yanagisawa, H	1
Ishimitsu, T; Matsuoka, H; Ono, H; Teranishi, M	1
Fogo, A; Hohenfellner, K; Kon, V	1
Crespo, MJ	1
Hojo, Y; Ikeda, U; Shimada, K	1
Baba, T; Gohda, T; Haneda, M; Kikkawa, R; Makita, Y; Shike, T; Tomino, Y; Watanabe, T; Yoshida, H	1
Peters, H; Ritz, E	1
Lohmeier, TE; Mizelle, HL; Montani, JP; Reinhart, GA	1
Fogo, AB	1
Hayes, PC; Helmy, A; Jalan, R; Newby, DE; Webb, DJ	1
Meyer, TW; Olson, JL; Pagtalunan, ME	1
Brown, NJ; Donnert, E; Fogo, AB; Freeman, M; Ma, L; Nakamura, I; Nakamura, S; Vaughan, DE	1
Krum, H	1
Schrier, RW	1
Hollenberg, NK	1
Flack, JM	1
Benigni, A; Remuzzi, G	1
Abraham, JA; Damm, D; Garrard, LJ; Henson, M; Joly, AH; Lam, A; Schreiner, GF; Stanton, LW; White, T	1
Benigni, A; Perico, N; Remuzzi, G	1
Kim, SD	1
Martínez-Maldonado, M	1
Bescos, M; Campistol, JM; Iñigo, P; Larios, S; Oppenheimer, F	1
Imura, Y; Matsuo, T; Nagano-Tsuge, H; Naka, T; Noda, M; Ohta, M; Sekiguchi, M; Shibouta, Y	1
Inagaki, K; Iwanaga, Y; Kataoka, K; Kihara, Y; Onozawa, Y; Sasayama, S; Yoneda, T	1
Luft, FC	1

Reviews

73 review(s) available for angiotensin ii and Disease Exacerbation

Article	Year
Impact of the gut microbiota on angiotensin Ⅱ-related disorders and its mechanisms. Biochemical pharmacology, 2023, Volume: 214 Topics: Angiotensin II; COVID-19; Diabetes Mellitus, Type 2; Disease Progression; Gastrointestinal Microbiome; Humans; Peptidyl-Dipeptidase A; Renin-Angiotensin System	2023
The endocrinological component and signaling pathways associated to cardiac hypertrophy. Molecular and cellular endocrinology, 2020, 12-01, Volume: 518 Topics: Angiotensin II; Animals; Cardiomegaly; Disease Progression; Endocrine System; Humans; Insulin; Signal Transduction; Thyroid Hormones	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Current evidence on the use of anti-RAAS agents in congenital or acquired solitary kidney. Renal failure, 2017, Volume: 39, Issue:1 Topics: Adult; Age Factors; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Child; Disease Progression; Female; Humans; Hypertension; Kidney; Male; Protective Agents; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Renin-Angiotensin System; Sex Factors; Solitary Kidney	2017
Animal models in the research of abdominal aortic aneurysms development. Physiological research, 2017, 12-20, Volume: 66, Issue:6 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Calcium Chloride; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Female; Genetic Predisposition to Disease; Hemodynamics; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pancreatic Elastase; Phenotype; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sus scrofa; Vascular Remodeling	2017
Retarding progression of chronic kidney disease: use of modalities that counter acid retention. Current opinion in nephrology and hypertension, 2018, Volume: 27, Issue:2 Topics: Acid-Base Imbalance; Aldosterone; Angiotensin II; Animals; Buffers; Citrates; Dietary Proteins; Disease Progression; Endothelins; Fibrosis; Fruit; Humans; Kidney; Renal Insufficiency, Chronic; Sodium Bicarbonate; Sodium Citrate; Vegetables	2018
Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms. Current drug targets, 2018, Volume: 19, Issue:11 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Aneurysm, Abdominal; Aortic Rupture; Clinical Trials as Topic; Disease Models, Animal; Disease Progression; Humans; Receptor, Angiotensin, Type 1; Telmisartan; Valsartan	2018
Neurovascular interactions in the retina: physiological and pathological roles. Journal of pharmacological sciences, 2013, Volume: 123, Issue:2 Topics: Angiotensin II; Catecholamines; Cell Communication; Diabetic Retinopathy; Disease Progression; Drug Discovery; Endothelin Receptor Antagonists; Endothelin-1; Glaucoma; Homeostasis; Molecular Targeted Therapy; N-Methylaspartate; Neuroglia; Neurons; Nitric Oxide; Nitric Oxide Synthase Type II; Potassium Channels, Calcium-Activated; Receptors, GABA; Retina; Retinal Diseases; Retinal Vessels	2013
A possible mechanism for the progression of chronic renal disease and congestive heart failure. Journal of the American Society of Hypertension : JASH, 2015, Volume: 9, Issue:1 Topics: Angiotensin II; Disease Progression; Heart Failure; Humans; Neurodegenerative Diseases; Renal Insufficiency, Chronic; Renin-Angiotensin System; Up-Regulation	2015
An Expanded View of Progressive Cardiorenal Disorders. The American journal of the medical sciences, 2016, Volume: 351, Issue:6 Topics: Angiotensin II; Angiotensinogen; Cardio-Renal Syndrome; Disease Progression; Heart Failure; Humans; Parathyroid Hormone-Related Protein; Peptidyl-Dipeptidase A; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A	2016
Role of the intrarenal renin-angiotensin system in the progression of renal disease. Pediatric nephrology (Berlin, Germany), 2017, Volume: 32, Issue:9 Topics: Angiotensin II; Angiotensinogen; Animals; Biomarkers; Disease Progression; Humans; Kidney; Kidney Diseases; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction	2017
A Reassessment of the Pathophysiology of Progressive Cardiorenal Disorders. The Medical clinics of North America, 2017, Volume: 101, Issue:1 Topics: Angiotensin II; Cardio-Renal Syndrome; Diabetic Nephropathies; Disease Progression; Humans; Intercellular Signaling Peptides and Proteins; Receptors, Mineralocorticoid; Renin-Angiotensin System; Signal Transduction	2017
IgA nephropathy: challenges and opportunities. Cleveland Clinic journal of medicine, 2008, Volume: 75, Issue:8 Topics: Angiotensin II; Diagnosis, Differential; Disease Progression; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Prognosis; Risk Factors	2008
Pharmacologic modulation of ACE2 expression. Current hypertension reports, 2008, Volume: 10, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Disease Progression; Humans; Hypertension; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System	2008
Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4 Topics: Acute Coronary Syndrome; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Atherosclerosis; Bradykinin; Cardiotonic Agents; Coronary Artery Disease; Disease Progression; Endothelial Cells; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Perindopril; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention; Stem Cells	2010
[Critical role of renin-angiotensin system in the pathogenesis of atherosclerosis]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Endothelium, Vascular; Humans; Inflammation; Reactive Oxygen Species; Renin-Angiotensin System	2011
Complex pathologies of angiotensin II-induced abdominal aortic aneurysms. Journal of Zhejiang University. Science. B, 2011, Volume: 12, Issue:8 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Connective Tissue; Disease Models, Animal; Disease Progression; Female; Humans; Hypercholesterolemia; Male; Mice; Peptides; Renin-Angiotensin System; Time Factors	2011
Roles of heterotrimeric GTP-binding proteins in the progression of heart failure. Journal of pharmacological sciences, 2011, Volume: 117, Issue:1 Topics: Angiotensin II; Calcium Channels; Diglycerides; Disease Progression; Heart Failure; Heterotrimeric GTP-Binding Proteins; Humans; Signal Transduction	2011
Renal oxidative stress, oxygenation, and hypertension. American journal of physiology. Regulatory, integrative and comparative physiology, 2011, Volume: 301, Issue:5 Topics: Angiotensin II; Animals; Antioxidants; Disease Progression; Fibrosis; Humans; Hypertension; Hypoxia; Kidney; Kidney Diseases; Oxidative Stress; Oxygen; Oxygen Consumption; Reactive Oxygen Species	2011
Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury. Clinical and experimental nephrology, 2012, Volume: 16, Issue:2 Topics: Angiotensin II; Animals; Disease Progression; Humans; Kidney Diseases; Kidney Glomerulus; Renin-Angiotensin System	2012
Renal microvascular dysfunction, hypertension and CKD progression. Current opinion in nephrology and hypertension, 2013, Volume: 22, Issue:1 Topics: Angiotensin II; Blood Pressure; Disease Progression; Homeostasis; Humans; Hypertension, Renal; Kidney Glomerulus; Microvessels; Nitric Oxide; Renal Insufficiency, Chronic	2013
Halting progression of renal failure: consideration beyond angiotensin II inhibition. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:11 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Disease Progression; Humans; Kidney Failure, Chronic; Risk Factors	2002
Comparative effects of ACE inhibition and angiotensin II receptor blockade in the prevention of renal damage. Kidney international. Supplement, 2002, Issue:82 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Disease Progression; Humans; Kidney Failure, Chronic; Nephritis, Interstitial; Plasma Kallikrein; Renin-Angiotensin System	2002
Angiotensin blockade in type 2 diabetic renal disease. Kidney international. Supplement, 2002, Issue:82 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Evidence-Based Medicine; Humans; Renin-Angiotensin System; Treatment Outcome	2002
Dopamine and the kidney: a role in hypertension? Current opinion in nephrology and hypertension, 2003, Volume: 12, Issue:2 Topics: Angiotensin II; Animals; Disease Models, Animal; Disease Progression; Dopamine; Female; Humans; Hypertension; Kidney Diseases; Male; Mice; Polymorphism, Genetic; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Dopamine; Renin-Angiotensin System; Sensitivity and Specificity; Sodium Chloride	2003
Progression of chronic renal disease. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 41, Issue:3 Suppl 1 Topics: Angiotensin II; Animals; Disease Progression; Growth Substances; Humans; Kidney Failure, Chronic; NF-kappa B; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2003
Angiotensin II and the glomerulus: focus on diabetic kidney disease. Current hypertension reports, 2003, Volume: 5, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Humans; Kidney Glomerulus; Renin-Angiotensin System	2003
[Proteases and antiproteases in the progression of chronic renal insufficiency lesions. The role of the tissue renin-angiotensin system and the renin receptor]. Journal de la Societe de biologie, 2002, Volume: 196, Issue:4 Topics: Angiotensin II; Disease Progression; Endocardium; Endopeptidases; Extracellular Matrix Proteins; Glomerular Mesangium; Humans; Kidney; Kidney Failure, Chronic; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Protease Inhibitors; Receptors, Cell Surface; Renin-Angiotensin System; Sclerosis; Vacuolar Proton-Translocating ATPases	2002
An update on 'progression promoters' in renal diseases. Journal of the National Medical Association, 2003, Volume: 95, Issue:1 Topics: Angiotensin II; Disease Progression; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Risk Factors	2003
Role of angiotensin II in the progression of diabetic nephropathy-therapeutic implications. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18 Suppl 5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Humans; Male; Prognosis; Receptors, Angiotensin; Renin-Angiotensin System; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome	2003
Treatment of diabetic nephropathy with angiotensin II blockers. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18 Suppl 5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Humans; Male; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Severity of Illness Index; Treatment Outcome	2003
[Programmed cellular death and atherogenesis: from molecular mechanisms to clinical aspects]. Medicina (Kaunas, Lithuania), 2003, Volume: 39, Issue:6 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Apoptosis; Arteriosclerosis; Calcium Channel Blockers; Caspases; Cholesterol; Disease Progression; Endothelium, Vascular; Humans; Hypolipidemic Agents; Macrophages; Muscle, Smooth, Vascular; Oxidative Stress	2003
Pathogenesis of diabetic retinopathy and the renin-angiotensin system. Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2003, Volume: 23, Issue:6 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetic Retinopathy; Disease Progression; Humans; Hyperglycemia; Hypertension; Macular Degeneration; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Vascular Endothelial Growth Factors	2003
Proteinuria and its consequences in renal disease. Acta paediatrica (Oslo, Norway : 1992). Supplement, 2003, Volume: 92, Issue:443 Topics: Angiotensin II; Chronic Disease; Disease Progression; Fabry Disease; Humans; Hyperlipidemias; Hypertension, Renal; Hypertrophy; Kidney Diseases; Kidney Glomerulus; Proteinuria	2003
Modulation of the inflammatory response in cardiovascular disease. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5 Topics: Angiotensin II; Animals; Blood Platelets; Cardiovascular Diseases; CD40 Antigens; CD40 Ligand; Cell Adhesion Molecules; Disease Progression; Endothelium, Vascular; Humans; Inflammation; Integrins; Models, Animal; Oxidative Stress; Renin-Angiotensin System; Risk Factors; Thrombophilia	2004
[IgA nephropathy]. La Revue du praticien, 2003, Nov-30, Volume: 53, Issue:18 Topics: Adrenal Cortex Hormones; Adult; Age Factors; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biopsy; Diagnosis, Differential; Disease Progression; Glomerulonephritis, IGA; Hematuria; Humans; Hypertension; Immunosuppressive Agents; Incidence; Kidney; Kidney Failure, Chronic; Prognosis; Proteinuria; Risk Factors; Time Factors	2003
Angiotensin in atherosclerosis. Current opinion in nephrology and hypertension, 2004, Volume: 13, Issue:3 Topics: Angiotensin II; Arteriosclerosis; Diabetes Mellitus; Disease Progression; Estrogens; Humans; Hyperlipidemias; Hypertension; Inflammation; Insulin Resistance; Risk Factors	2004
Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure. Cardiovascular research, 2004, Aug-15, Volume: 63, Issue:3 Topics: Angiotensin II; Animals; Cardiomyopathy, Dilated; Cytokines; Disease Progression; Humans; Interleukins; Renin-Angiotensin System; Signal Transduction; Tumor Necrosis Factor-alpha	2004
[Renoprotective effects of antihypertensives]. Vnitrni lekarstvi, 2004, Volume: 50, Issue:7 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Disease Progression; Humans; Kidney; Kidney Failure, Chronic; Protective Agents	2004
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? Circulation, 2004, Nov-16, Volume: 110, Issue:20 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Heart Failure; Humans; Hypotension; Mineralocorticoid Receptor Antagonists; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Spironolactone; Ventricular Dysfunction, Left	2004
Disruptions and detours in the myocardial matrix highway and heart failure. Current heart failure reports, 2005, Volume: 2, Issue:1 Topics: Angiotensin II; Disease Progression; Endothelin-1; Extracellular Matrix; Heart Failure; Humans; Hypertrophy, Left Ventricular; Integrins; Matrix Metalloproteinases; Myocardial Infarction; Myocardium; Transforming Growth Factor beta; Ventricular Remodeling	2005
[The renin-angiotensin-aldosterone system -- more complex as previously thought]. Medizinische Klinik (Munich, Germany : 1983), 2005, Aug-15, Volume: 100, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Chymases; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Humans; Indoles; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Prospective Studies; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Serine Endopeptidases	2005
Pharmacological management of renal fibrotic disease. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Disease Progression; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fibrosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Diseases; Practice Guidelines as Topic; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Transforming Growth Factor beta	2006
[Molecular mechanisms of progression in renal failure]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 2 Topics: Ammonia; Angiotensin II; Animals; Disease Progression; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Kidney Tubules; Nephrons; Oxidative Stress; Proteinuria; Renal Insufficiency	2006
[Renin-angiotensin system in atherosclerosis]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Disease Progression; Endothelium, Vascular; Humans; Inflammation; Reactive Oxygen Species; Renin-Angiotensin System	2006
Neovascularization in human atherosclerosis. Circulation, 2006, May-09, Volume: 113, Issue:18 Topics: Angiotensin II; Animals; Aryl Hydrocarbon Receptor Nuclear Translocator; Atherosclerosis; Blood Proteins; Capillary Permeability; Cell Hypoxia; Chemotaxis, Leukocyte; Coronary Artery Disease; Coronary Vessels; Diagnostic Imaging; Disease Progression; Hemorrhage; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophage Activation; Membrane Lipids; Models, Animal; Neovascularization, Physiologic; Oxidative Stress; Sus scrofa; Sympathetic Nervous System; Tunica Intima; Vasa Vasorum; Vascular Endothelial Growth Factor A	2006
Role of transforming growth factor-beta in the progression of heart failure. Cellular and molecular life sciences : CMLS, 2006, Volume: 63, Issue:22 Topics: Angiotensin II; Animals; Cardiac Output, Low; Chronic Disease; Disease Progression; Heart Diseases; Humans; Myocardium; Signal Transduction; Transforming Growth Factor beta; Ventricular Remodeling	2006
Lipids and diabetic nephropathy. Current diabetes reports, 2006, Volume: 6, Issue:6 Topics: Angiotensin II; Animals; Apolipoproteins E; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Dyslipidemias; Glycation End Products, Advanced; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Polymorphism, Genetic; Safety	2006
Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clinical science (London, England : 1979), 2007, Volume: 112, Issue:7 Topics: Aldosterone; Angiotensin II; Cell Adhesion Molecules; Cytokines; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Progression; Humans; Hypertension; NF-kappa B; Renin-Angiotensin System; Vasculitis	2007
Pathophysiology of target-organ disease: does angiotensin II remain the key? Journal of clinical hypertension (Greenwich, Conn.), 2007, Volume: 9, Issue:11 Suppl 4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Disease Progression; Humans; Hypertension; Losartan; Myocardial Infarction; Renin; Renin-Angiotensin System; Stroke; Tetrazoles; Treatment Outcome; Valine; Valsartan	2007
T-cells in angiotensin-II-induced vascular damage. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Blood Vessels; Chemokine CCL5; Disease Progression; Humans; Hypertension, Renal; Immunity, Cellular; T-Lymphocytes; Vasoconstriction; Vasoconstrictor Agents	2008
Cellular and molecular mechanisms of fibrosis. The Journal of pathology, 2008, Volume: 214, Issue:2 Topics: Angiotensin II; Chemokines; Chemotaxis; Cytokines; Disease Progression; Fibroblasts; Fibrosis; Humans; Immunity, Innate; Interleukins; Th1 Cells; Th2 Cells; Transforming Growth Factor beta	2008
A clinical approach in regression of glomerulosclerosis. Romanian journal of internal medicine = Revue roumaine de medecine interne, 2007, Volume: 45, Issue:2 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Disease Progression; Glomerulosclerosis, Focal Segmental; Humans; Plasminogen Activator Inhibitor 1; Rats; Renin-Angiotensin System	2007
Left ventricular hypertrophy in mild essential hypertension. Its progression, prediction and treatment strategy. Japanese heart journal, 1996, Volume: 37, Issue:4 Topics: Angiotensin II; Antihypertensive Agents; Arteriosclerosis; Disease Progression; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Norepinephrine	1996
Angiotensin in progressive renal diseases: theory and practice. Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:10 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Progression; Environment; Humans; Kidney Diseases; Models, Biological	1996
Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review. Seminars in nephrology, 1997, Volume: 17, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Progression; Hemodynamics; Kidney Diseases; Rats; Renin-Angiotensin System	1997
Renal tubular hypertrophy induced by angiotensin II. Seminars in nephrology, 1997, Volume: 17, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cells, Cultured; Disease Models, Animal; Disease Progression; Hypertrophy; Kidney Diseases; Kidney Tubules; Rats; Renin-Angiotensin System	1997
Angiotensin II receptor blockade and progression of nondiabetic-mediated renal disease. Kidney international. Supplement, 1997, Volume: 63 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Disease Progression; Humans; Kidney Diseases	1997
[HgCl2-induced acute renal failure and its pathophysiology]. Nihon eiseigaku zasshi. Japanese journal of hygiene, 1998, Volume: 52, Issue:4 Topics: Acute Kidney Injury; Angiotensin II; Animals; Disease Progression; Endothelin-1; Glomerular Filtration Rate; Humans; Kidney Tubular Necrosis, Acute; Mercuric Chloride; Vascular Resistance	1998
Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:5 Topics: Adjuvants, Immunologic; Angiotensin II; Animals; Cytokines; Disease Progression; Growth Substances; Hemodynamics; Humans; Kidney; Kidney Diseases	1998
Angiotensin II: a pivotal factor in the progression of renal diseases. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14 Suppl 1 Topics: Angiotensin II; Animals; Disease Progression; Humans; Kidney; Kidney Diseases	1999
Renin-angiotensin genes in renal development and the occurrence and progression of renal diseases. Seminars in nephrology, 1999, Volume: 19, Issue:2 Topics: Angiotensin II; Animals; Disease Progression; Female; Humans; Kidney; Kidney Diseases; Male; Mice; Renin-Angiotensin System	1999
Dosing angiotensin II blockers--beyond blood pressure. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Progression; Dose-Response Relationship, Drug; Humans; Kidney Diseases	1999
The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 35, Issue:2 Topics: Angiotensin II; Disease Progression; Endothelium; Glomerulosclerosis, Focal Segmental; Hemodynamics; Humans; Plasminogen Activator Inhibitor 1	2000
Recent advances in the management of chronic heart failure. Australian and New Zealand journal of medicine, 2000, Volume: 30, Issue:4 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Cytokines; Disease Progression; Endothelin-1; Heart Failure; Humans	2000
Treating high-risk diabetic hypertensive patients with comorbid conditions. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:3 Suppl 1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Disease Progression; Humans; Hypertension; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors	2000
Impact of angiotensin II on the kidney: does an angiotensin II receptor blocker make sense? American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:3 Suppl 1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blood Volume; Clinical Trials as Topic; Diabetes Mellitus; Disease Progression; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Kidney; Peptidyl-Dipeptidase A; Proteinuria; Renin-Angiotensin System; Vasodilator Agents; Water-Electrolyte Balance	2000
Angiotensin II as a mediator of tubulointerstitial injury. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15 Suppl 6 Topics: Angiotensin II; Animals; Disease Progression; Kidney Diseases; Kidney Tubules	2000
Research on renal endothelin in proteinuric nephropathies dictates novel strategies to prevent progression. Current opinion in nephrology and hypertension, 2001, Volume: 10, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Progression; Endothelin Receptor Antagonists; Endothelins; Humans; Kidney; Kidney Diseases; Proteinuria	2001
Measurement of the renin-angiotensin system in heart failure. Biological research for nursing, 2000, Volume: 1, Issue:3 Topics: Angiotensin II; Disease Progression; Heart Failure; Hemodynamics; Humans; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Renin; Renin-Angiotensin System	2000
Role of hypertension in the progression of chronic renal disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Black or African American; Black People; Chronic Disease; Disease Progression; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Muscle, Smooth, Vascular; United States	2001
Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16 Suppl 1 Topics: Angiotensin II; Antihypertensive Agents; Biomarkers; Disease Progression; Endothelin-1; Humans; Kidney Transplantation; Losartan; Renin-Angiotensin System; Transforming Growth Factor beta; Transplantation, Homologous	2001
Proinflammatory effects of angiotensin II and endothelin: targets for progression of cardiovascular and renal diseases. Current opinion in nephrology and hypertension, 2002, Volume: 11, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Disease Progression; Endothelins; Humans; Inflammation; Kidney Diseases; Nitric Oxide; Receptor, Angiotensin, Type 1	2002

Trials

4 trial(s) available for angiotensin ii and Disease Exacerbation

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial. Transplantation, 2014, May-27, Volume: 97, Issue:10 Topics: Allografts; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atrophy; Biopsy; Chronic Disease; Creatinine; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Hyperuricemia; Kidney Failure, Chronic; Kidney Transplantation; Kidney Tubules; Male; Middle Aged; Nephritis, Interstitial; Treatment Outcome; Uric Acid	2014
Beneficial effects of pioglitazone on retardation of persistent atrial fibrillation progression in diabetes mellitus patients. International heart journal, 2014, Volume: 55, Issue:6 Topics: Aged; Angiotensin II; Atrial Fibrillation; Diabetes Complications; Disease Progression; Double-Blind Method; Female; Glycation End Products, Advanced; Heart Atria; Humans; Hypoglycemic Agents; Male; Middle Aged; Peptide Fragments; Pioglitazone; Procollagen; Thiazolidinediones	2014
Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron, 1999, Volume: 82, Issue:2 Topics: Aged; Angiotensin II; Angiotensinogen; Diabetes Mellitus, Type 2; Disease Progression; DNA; Female; Genotype; Humans; Japan; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Angiotensin	1999

Other Studies

206 other study(ies) available for angiotensin ii and Disease Exacerbation

Article	Year
mTOR inhibition prevents angiotensin II-induced aortic rupture and pseudoaneurysm but promotes dissection in Apoe-deficient mice. JCI insight, 2022, 02-08, Volume: 7, Issue:3 Topics: Aneurysm, False; Angiotensin II; Animals; Aortic Aneurysm, Thoracic; Aortic Rupture; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; MTOR Inhibitors; RNA; TOR Serine-Threonine Kinases	2022
Macrophage metabolic reprogramming aggravates aortic dissection through the HIF1α-ADAM17 pathway EBioMedicine, 2019, Volume: 49 Topics: Acriflavine; ADAM17 Protein; Aminopropionitrile; Angiotensin II; Animals; Aortic Dissection; Disease Models, Animal; Disease Progression; HEK293 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophages; Male; Mice, Inbred C57BL; Up-Regulation	2019
MiR-326 targets MDK to regulate the progression of cardiac hypertrophy through blocking JAK/STAT and MAPK signaling pathways. European journal of pharmacology, 2020, Apr-05, Volume: 872 Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Disease Models, Animal; Disease Progression; Down-Regulation; Humans; Janus Kinases; Male; MAP Kinase Signaling System; Mice; MicroRNAs; Midkine; Myocytes, Cardiac; Rats; STAT Transcription Factors	2020
Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy. Clinical science (London, England : 1979), 2020, 02-14, Volume: 134, Issue:3 Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Collagen; Collagen Type I, alpha 1 Chain; Disease Models, Animal; Disease Progression; Electrocardiography; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Inflammation; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Nuclear Receptor Subfamily 4, Group A, Member 3; Transcription, Genetic; Ventricular Remodeling	2020
Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease. Journal of the American Society of Nephrology : JASN, 2020, Volume: 31, Issue:3 Topics: Acid-Base Equilibrium; Acidosis; Adaptation, Physiological; Aldosterone; Angiotensin II; Biomarkers; Disease Progression; Endothelin-1; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Prospective Studies; Renal Insufficiency, Chronic; Retrospective Studies; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome	2020
The Demonstration of an Aqp4/Tgf-beta 1 Pathway in Murine Astrocytes Holds Implications for Both Neuromyelitis Optica and Progressive Multiple Sclerosis. International journal of molecular sciences, 2020, Feb-04, Volume: 21, Issue:3 Topics: Angiotensin II; Animals; Aquaporin 4; Astrocytes; Disease Progression; Inflammation; Mice; Multiple Sclerosis; Neuromyelitis Optica; Signal Transduction; Transforming Growth Factor beta1	2020
Quercetin Dihydrate inhibition of cardiac fibrosis induced by angiotensin II in vivo and in vitro. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 127 Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Collagen Type I; Collagen Type III; Disease Models, Animal; Disease Progression; Fibroblasts; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myocardium; Quercetin; Rats	2020
LncRNA LBX2-AS1 facilitates abdominal aortic aneurysm through miR-4685-5p/LBX2 feedback loop. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 129 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Disease Progression; Feedback, Physiological; Female; Gene Expression Regulation; Homeodomain Proteins; Humans; Mice; MicroRNAs; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; RNA, Long Noncoding; Signal Transduction	2020
All-trans retinoic acid attenuates the progression of Ang II-induced abdominal aortic aneurysms in ApoE Journal of cardiothoracic surgery, 2020, Jul-02, Volume: 15, Issue:1 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Disease Models, Animal; Disease Progression; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Knockout, ApoE; Tretinoin	2020
Ex vivo magnetic particle imaging of vascular inflammation in abdominal aortic aneurysm in a murine model. Scientific reports, 2020, 07-24, Volume: 10, Issue:1 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Disease Models, Animal; Disease Progression; Feasibility Studies; Humans; Inflammation; Magnetic Iron Oxide Nanoparticles; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Knockout, ApoE	2020
Progression and regression of left ventricular hypertrophy and myocardial fibrosis in a mouse model of hypertension and concomitant cardiomyopathy. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2020, 08-06, Volume: 22, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Disease Progression; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Mice, Inbred C57BL; Myocardium; Time Factors; Ventricular Function, Left; Ventricular Remodeling	2020
Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis. Hepatology international, 2020, Volume: 14, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Apoptosis; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; Disease Progression; Disease Susceptibility; Humans; Liver Cirrhosis; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Preliminary Data; SARS-CoV-2; Up-Regulation	2020
Vitamin D deficiency promotes large rupture-prone abdominal aortic aneurysms and cholecalciferol supplementation limits progression of aneurysms in a mouse model. Clinical science (London, England : 1979), 2020, 09-30, Volume: 134, Issue:18 Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Apolipoproteins E; Blood Pressure; Caloric Restriction; Cholecalciferol; Dietary Supplements; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Humans; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Up-Regulation; Vitamin D Deficiency	2020
Prevention of Progression of Aortic Aneurysm by Peptide Vaccine Against Ang II (Angiotensin II) in a Rat Model. Hypertension (Dallas, Tex. : 1979), 2020, Volume: 76, Issue:6 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Disease Models, Animal; Disease Progression; Hemocyanins; Immunoconjugates; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; NF-kappa B; Rats, Wistar; Signal Transduction; Vaccines, Subunit	2020
Gal-1 (Galectin-1) Upregulation Contributes to Abdominal Aortic Aneurysm Progression by Enhancing Vascular Inflammation. Arteriosclerosis, thrombosis, and vascular biology, 2021, Volume: 41, Issue:1 Topics: Adventitia; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortitis; Case-Control Studies; Cells, Cultured; Cytokines; Disease Models, Animal; Disease Progression; Extracellular Matrix; Fibroblasts; Galectin 1; Humans; Inflammation Mediators; Macrophages, Peritoneal; Male; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Mice, Knockout, ApoE; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Signal Transduction; Up-Regulation; Vascular Remodeling	2021
Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation. Vascular pharmacology, 2021, Volume: 136 Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortitis; Calcium Chloride; Cell Adhesion Molecules; Cytokines; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Factor Xa Inhibitors; Humans; Inflammation Mediators; Male; Mice, Knockout, ApoE; Retrospective Studies; Rivaroxaban; Signal Transduction; Vascular Remodeling	2021
Establishment and effect evaluation of an aortic dissection model induced by different doses of β-aminopropionitrile in rats. Vascular, 2021, Volume: 29, Issue:6 Topics: Aminopropionitrile; Angiotensin II; Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Magnetic Resonance Imaging; Male; Rats, Sprague-Dawley; Time Factors; Vascular Remodeling	2021
Early Detection of Aortic Degeneration in a Mouse Model of Sporadic Aortic Aneurysm and Dissection Using Nanoparticle Contrast-Enhanced Computed Tomography. Arteriosclerosis, thrombosis, and vascular biology, 2021, Volume: 41, Issue:4 Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm; Aortic Dissection; Aortic Rupture; Aortography; Computed Tomography Angiography; Contrast Media; Diet, High-Fat; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Early Diagnosis; Male; Mice, Inbred C57BL; Nanoparticles; Predictive Value of Tests; Time Factors; Triiodobenzoic Acids; X-Ray Microtomography	2021
Myocardial Angiotensin Metabolism in End-Stage Heart Failure. Journal of the American College of Cardiology, 2021, 04-13, Volume: 77, Issue:14 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Disease Progression; Female; Heart Failure; Heart Transplantation; Humans; Male; Mass Spectrometry; Middle Aged; Myocardium; Peptide Fragments; Renin-Angiotensin System; Stroke Volume	2021
High serum thrombospondin-1 concentration is associated with slower abdominal aortic aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice. Clinical science (London, England : 1979), 2017, Jun-01, Volume: 131, Issue:12 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Biomarkers; Cells, Cultured; Collagen Type III; Disease Models, Animal; Disease Progression; Elastin; Genetic Predisposition to Disease; Humans; Low Density Lipoprotein Receptor-Related Protein-1; Male; Matrix Metalloproteinase 9; Mice, Knockout; Odds Ratio; Phenotype; Proteolysis; Receptors, LDL; Risk Factors; Thrombospondin 1; Time Factors; Tumor Suppressor Proteins; Ultrasonography; Vascular Remodeling	2017
Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging. PloS one, 2017, Volume: 12, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Diltiazem; Disease Progression; Enalapril; Gene Expression Regulation; Heart; Kidney; Male; Organ Size; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Regional Blood Flow; Renal Insufficiency, Chronic	2017
The loss of Krüppel-like factor 15 in Foxd1 Kidney international, 2017, Volume: 92, Issue:5 Topics: Angiotensin II; Animals; beta Catenin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Disease Progression; DNA-Binding Proteins; Fibrosis; Forkhead Transcription Factors; Gene Expression Regulation; Gene Knockdown Techniques; Kidney; Kidney Diseases; Kruppel-Like Transcription Factors; Male; Mice; Mice, Inbred C57BL; Myofibroblasts; Phosphorylation; RNA, Messenger; Stromal Cells; Transcription Factors; Wnt Signaling Pathway; Wnt1 Protein	2017
Angiotensin 1-7 inhibits angiotensin II-stimulated head and neck cancer progression. European journal of oral sciences, 2017, Volume: 125, Issue:4 Topics: Angiotensin I; Angiotensin II; Cell Culture Techniques; Cell Movement; Disease Progression; Fibroblasts; Head and Neck Neoplasms; Humans; Immunoblotting; Peptide Fragments; Polymerase Chain Reaction; Renin-Angiotensin System; Signal Transduction; Transfection; Tumor Cells, Cultured	2017
Sirtuin 3 Deficiency Accelerates Hypertensive Cardiac Remodeling by Impairing Angiogenesis. Journal of the American Heart Association, 2017, Aug-19, Volume: 6, Issue:8 Topics: Acetylation; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen Type I; Collagen Type III; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Hypertension; Mice, 129 Strain; Mice, Knockout; Mitochondria, Heart; Mitophagy; Myocardium; Neovascularization, Physiologic; Oxidative Stress; Phenotype; Protein Kinases; Signal Transduction; Sirtuin 3; Time Factors; Tissue Culture Techniques; Ubiquitin-Protein Ligases; Ventricular Remodeling	2017
Angiotensin II infusion into ApoE-/- mice: a model for aortic dissection rather than abdominal aortic aneurysm? Cardiovascular research, 2017, Aug-01, Volume: 113, Issue:10 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Dissection; Aortography; Computed Tomography Angiography; Disease Models, Animal; Disease Progression; Hematoma; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Time Factors; Ultrasonography, Doppler, Pulsed; Vascular Remodeling; X-Ray Microtomography	2017
Endothelial Journal of the American Society of Nephrology : JASN, 2017, Volume: 28, Issue:12 Topics: Albumins; Angiotensin II; Animals; Basic Helix-Loop-Helix Transcription Factors; Blood Pressure; Cell Differentiation; Crosses, Genetic; Disease Progression; Epithelial Cells; Gene Deletion; Gene Expression Regulation; Glomerulosclerosis, Focal Segmental; Hypertension; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Podocytes; Telemetry	2017
Stimulation of ganglionated plexus attenuates cardiac neural remodeling and heart failure progression in a canine model of acute heart failure post-myocardial infarction. Autonomic neuroscience : basic & clinical, 2017, Volume: 208 Topics: Angiotensin II; Animals; Biomarkers; Disease Models, Animal; Disease Progression; Dogs; Electric Stimulation Therapy; GAP-43 Protein; Heart; Heart Failure; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Nerve Growth Factor; Norepinephrine; Parasympathetic Nervous System; Proto-Oncogene Proteins c-fos; Random Allocation; Tyrosine 3-Monooxygenase	2017
Angiotensin II-C-C chemokine receptor2/5 axis-dependent monocyte/macrophage recruitment contributes to progression of experimental autoimmune myocarditis. Microbiology and immunology, 2017, Volume: 61, Issue:12 Topics: Angiotensin II; Animals; Autoimmune Diseases; Disease Progression; Female; Humans; Macrophages; Male; Mice; Mice, Inbred BALB C; Monocytes; Myocarditis; Receptors, CCR2; Receptors, CCR5	2017
MicroRNA-21 Knockout Exacerbates Angiotensin II-Induced Thoracic Aortic Aneurysm and Dissection in Mice With Abnormal Transforming Growth Factor-β-SMAD3 Signaling. Arteriosclerosis, thrombosis, and vascular biology, 2018, Volume: 38, Issue:5 Topics: Angiotensin II; Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Aortic Rupture; Cells, Cultured; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Genetic Predisposition to Disease; JNK Mitogen-Activated Protein Kinases; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenotype; Phosphorylation; Signal Transduction; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta	2018
H19 Induces Abdominal Aortic Aneurysm Development and Progression. Circulation, 2018, 10-09, Volume: 138, Issue:15 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis; Case-Control Studies; Cells, Cultured; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pancreatic Elastase; Receptors, LDL; RNA, Long Noncoding; Swine; Swine, Miniature; Tumor Suppressor Protein p53; Up-Regulation	2018
Development and growth trends in angiotensin II-induced murine dissecting abdominal aortic aneurysms. Physiological reports, 2018, Volume: 6, Issue:8 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Aortic Dissection; Apolipoproteins E; Disease Models, Animal; Disease Progression; Male; Mice; Ultrasonography	2018
Involvement of the renin-angiotensin system in the progression of severe hand-foot-and-mouth disease. PloS one, 2018, Volume: 13, Issue:5 Topics: Angiotensin II; Animals; Child, Preschool; Disease Progression; Enterovirus A, Human; Female; Foot-and-Mouth Disease; Humans; Infant; Male; Norepinephrine; Renin-Angiotensin System	2018
Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathy. Laboratory investigation; a journal of technical methods and pathology, 2018, Volume: 98, Issue:9 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Feedback, Physiological; Female; Fibrosis; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Sex Characteristics	2018
Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice. Journal of molecular and cellular cardiology, 2018, Volume: 123 Topics: Angiotensin II; Animals; Biomarkers; Biopsy; Blood Pressure; Cilostazol; Diastole; Disease Models, Animal; Disease Progression; Echocardiography; Energy Metabolism; Fibrosis; Heart Failure; Hypertension; Immunohistochemistry; Male; Mice; Renin; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left	2018
Long-Term Effects of the Abdominal Aortic Aneurysm Model in Rabbits Prepared by Pancreatic Elastase Combined With Angiotensin II. Vascular and endovascular surgery, 2019, Volume: 53, Issue:1 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Hemodynamics; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Pancreatic Elastase; Rabbits; Time Factors; Ultrasonography, Doppler, Color; Vascular Remodeling	2019
Sex-dependent differences in the adverse renal changes induced by an early in life exposure to a high-fat diet. American journal of physiology. Renal physiology, 2019, 02-01, Volume: 316, Issue:2 Topics: Abdominal Fat; Adipokines; Adiposity; Age Factors; Albuminuria; Angiotensin II; Animals; Arterial Pressure; Diet, High-Fat; Disease Progression; Female; Hypertension; Inflammation Mediators; Kidney; Kidney Diseases; Male; Obesity; Rats, Sprague-Dawley; Sex Factors; Time Factors	2019
Cardiomyocyte calcineurin is required for the onset and progression of cardiac hypertrophy and fibrosis in adult mice. The FEBS journal, 2019, Volume: 286, Issue:1 Topics: Angiotensin II; Animals; Calcineurin; Cardiomegaly; Disease Progression; Fibrosis; Gene Expression Profiling; Mice; Mice, Knockout; Myocytes, Cardiac; Signal Transduction; Vasoconstrictor Agents	2019
NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice. Circulation. Arrhythmia and electrophysiology, 2019, Volume: 12, Issue:1 Topics: Action Potentials; Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Disease Models, Animal; Disease Progression; Fibrosis; Heart Atria; Heart Rate; Hypertension; Male; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Receptors, Atrial Natriuretic Factor; Time Factors	2019
SP1-SYNE1-AS1-miR-525-5p feedback loop regulates Ang-II-induced cardiac hypertrophy. Journal of cellular physiology, 2019, Volume: 234, Issue:8 Topics: Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Cytoskeletal Proteins; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Humans; Mice; MicroRNAs; Myocytes, Cardiac; Nerve Tissue Proteins; RNA, Long Noncoding; Sp1 Transcription Factor; Transcriptional Activation	2019
Angiotensin II and tumor necrosis factor-α stimulate the growth, migration and invasion of BEL-7402 cells via down-regulation of GRK2 expression. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019, Volume: 51, Issue:2 Topics: Angiotensin II; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Disease Progression; Down-Regulation; G-Protein-Coupled Receptor Kinase 2; Humans; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Receptor, Angiotensin, Type 1; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor-alpha	2019
Concurrent Molecular Magnetic Resonance Imaging of Inflammatory Activity and Extracellular Matrix Degradation for the Prediction of Aneurysm Rupture. Circulation. Cardiovascular imaging, 2019, Volume: 12, Issue:3 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Contrast Media; Disease Models, Animal; Disease Progression; Elastin; Extracellular Matrix; Feasibility Studies; Ferrosoferric Oxide; Gadolinium DTPA; Inflammation Mediators; Magnetic Resonance Imaging; Male; Mice, Knockout, ApoE; Molecular Imaging; Predictive Value of Tests; Reproducibility of Results; Time Factors	2019
Accelerated Marfan syndrome model recapitulates established signaling pathways. The Journal of thoracic and cardiovascular surgery, 2020, Volume: 159, Issue:5 Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm; Cardiomyopathies; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Fibrillin-1; Genetic Predisposition to Disease; Heterozygote; Marfan Syndrome; Mice, Mutant Strains; Mutation; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenotype; Phosphorylation; Signal Transduction; Smad2 Protein; Time Factors; Transforming Growth Factor beta	2020
Erythrocyte Adenosine A2B Receptor-Mediated AMPK Activation: A Missing Component Counteracting CKD by Promoting Oxygen Delivery. Journal of the American Society of Nephrology : JASN, 2019, Volume: 30, Issue:8 Topics: 2,3-Diphosphoglycerate; Adult; AMP-Activated Protein Kinases; Angiotensin II; Animals; Disease Progression; Erythrocytes; Female; Humans; Hypoxia; Kidney Failure, Chronic; Male; Metabolomics; Mice; Middle Aged; Models, Genetic; Oxygen; Receptor, Adenosine A2B; Signal Transduction	2019
Tropoelastin: an in vivo imaging marker of dysfunctional matrix turnover during abdominal aortic dilation. Cardiovascular research, 2020, 04-01, Volume: 116, Issue:5 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Dissection; Biomarkers; Contrast Media; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Extracellular Matrix; Humans; Magnetic Resonance Imaging; Mice, Knockout, ApoE; Predictive Value of Tests; Proof of Concept Study; Time Factors; Tropoelastin; Up-Regulation; Vascular Remodeling	2020
Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects. The Journal of thoracic and cardiovascular surgery, 2013, Volume: 146, Issue:6 Topics: Aminopropionitrile; Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Disease Progression; Inflammation Mediators; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Sirtuin 1; Time Factors; Tumor Necrosis Factor-alpha	2013
Intravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouse. Journal of translational medicine, 2013, Jul-22, Volume: 11 Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm; Apolipoproteins E; Bone Marrow Cells; Cytokines; Disease Progression; Elastin; Femur; Inflammation; Injections, Intravenous; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Mice, Knockout	2013
Immunosuppressive drug azathioprine reduces aneurysm progression through inhibition of Rac1 and c-Jun-terminal-N-kinase in endothelial cells. Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:10 Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Aneurysm; Aortic Rupture; Apolipoproteins E; Azathioprine; Cell Line, Tumor; Coculture Techniques; Disease Models, Animal; Disease Progression; Endothelial Cells; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Immunosuppressive Agents; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Mercaptopurine; Mice; Mice, Knockout; Monocytes; Neuropeptides; Phosphorylation; Protein Kinase Inhibitors; rac1 GTP-Binding Protein; Signal Transduction	2013
Role of expression of endothelin-1 and angiotensin-II and hypoxia-inducible factor-1α in the kidney tissues of patients with diabetic nephropathy. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2013, Volume: 24, Issue:5 Topics: Adult; Aged; Angiotensin II; Diabetic Nephropathies; Disease Progression; Endothelin-1; Female; Fibrosis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Kidney; Male; Middle Aged; Nephritis, Interstitial	2013
A novel heart failure mice model of hypertensive heart disease by angiotensin II infusion, nephrectomy, and salt loading. American journal of physiology. Heart and circulatory physiology, 2013, Dec-01, Volume: 305, Issue:11 Topics: Angiotensin II; Animals; Animals, Newborn; Blood Pressure; Cells, Cultured; Disease Models, Animal; Disease Progression; Fibrosis; Gene Expression Regulation; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Myocardium; Nephrectomy; Neuropeptides; Oxidative Stress; Pulmonary Edema; rac1 GTP-Binding Protein; Rats; Rats, Wistar; Sodium Chloride, Dietary; Time Factors; Ventricular Function, Left	2013
Subservient relationship of the peripheral second systolic pressure peak to the central hemodynamic parameters is preserved, irrespective of atherosclerosis progression in hypercholesterolemic rabbits. Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:1 Topics: Angiotensin II; Animals; Atherosclerosis; Blood Pressure; Disease Progression; Hemodynamics; Hypercholesterolemia; Hypertension; Male; Nitroprusside; Rabbits; Vasoconstrictor Agents; Vasodilator Agents	2014
Inhalation of diesel exhaust does not exacerbate cardiac hypertrophy or heart failure in two mouse models of cardiac hypertrophy. Particle and fibre toxicology, 2013, Oct-05, Volume: 10 Topics: Air Pollutants; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Disease Progression; Echocardiography; Heart Failure; Heart Rate; Inhalation Exposure; Male; Mice; Mice, Inbred C57BL; Particle Size; Particulate Matter; Time Factors; Vehicle Emissions	2013
Interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosis. International journal of medical sciences, 2013, Volume: 10, Issue:12 Topics: Angiotensin II; Cholesterol; Diabetic Nephropathies; Disease Progression; Endoplasmic Reticulum; Gene Expression Regulation; Humans; Hydroxycholesterols; Intracellular Signaling Peptides and Proteins; Lipid Metabolism; Membrane Proteins; Mesangial Cells; ras Proteins; Receptor, Angiotensin, Type 1; Receptors, Lipoprotein; Renin-Angiotensin System; Sterol Regulatory Element Binding Protein 2; Sterol Regulatory Element Binding Proteins	2013
Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading. Clinical and experimental nephrology, 2014, Volume: 18, Issue:4 Topics: Albuminuria; Amides; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Cytoprotection; Disease Models, Animal; Disease Progression; Down-Regulation; Fumarates; Humans; Hydralazine; Hypertension; Kidney; Kidney Diseases; Mice; Mice, Transgenic; Ramipril; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Time Factors	2014
IQGAP1 mediates angiotensin II-induced apoptosis of podocytes via the ERK1/2 MAPK signaling pathway. American journal of nephrology, 2013, Volume: 38, Issue:5 Topics: Angiotensin II; Animals; Apoptosis; Disease Progression; Gene Expression Regulation; Kidney Glomerulus; Male; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Podocytes; ras GTPase-Activating Proteins; Rats; Rats, Wistar	2013
Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. The Journal of clinical investigation, 2014, Volume: 124, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Aneurysm; Cells, Cultured; Disease Progression; Female; Haploinsufficiency; Humans; Loeys-Dietz Syndrome; Losartan; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Transgenic; Mutation, Missense; Myocytes, Smooth Muscle; Phenotype; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta	2014
A disintegrin and metalloproteinase 17 (ADAM17) mediates epidermal growth factor receptor transactivation by angiotensin II on hepatic stellate cells. Life sciences, 2014, Mar-03, Volume: 97, Issue:2 Topics: ADAM Proteins; ADAM17 Protein; Amphiregulin; Angiotensin II; Blotting, Western; Cell Line; Cell Proliferation; Dipeptides; Disease Progression; EGF Family of Proteins; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Gene Silencing; Glycoproteins; Hepatic Stellate Cells; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Liver Cirrhosis	2014
Angiotensin II promotes the progression of human gastric cancer. Molecular medicine reports, 2014, Volume: 9, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gastric Mucosa; Humans; Losartan; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stomach Neoplasms; Transplantation, Heterologous	2014
Castration of male mice prevents the progression of established angiotensin II-induced abdominal aortic aneurysms. Journal of vascular surgery, 2015, Volume: 61, Issue:3 Topics: Actins; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Biomarkers; Cells, Cultured; Collagen; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Male; Mice, Inbred C57BL; Mice, Knockout; Orchiectomy; Risk Factors; Sex Factors; Testosterone; Time Factors; Ultrasonography; Vascular Remodeling	2015
Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nature communications, 2014, May-06, Volume: 5 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Biomarkers; C-Reactive Protein; Disease Progression; Female; Humans; Influenza A Virus, H7N9 Subtype; Influenza, Human; Male; Middle Aged; Prognosis; Viral Load	2014
Regulator of G protein signaling 2 (RGS2) deficiency accelerates the progression of kidney fibrosis. Biochimica et biophysica acta, 2014, Volume: 1842, Issue:9 Topics: Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Disease Progression; Female; Fibrosis; Humans; Immunoenzyme Techniques; Kidney Diseases; Mice; Mice, Knockout; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RGS Proteins; RNA, Messenger; Ureteral Obstruction	2014
Renal sympathetic denervation suppresses ventricular substrate remodelling in a canine high-rate pacing model. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Volume: 10, Issue:3 Topics: Aldosterone; Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Catheter Ablation; Disease Models, Animal; Disease Progression; Dogs; Female; Fibrosis; Heart Failure; Heart Ventricles; Kidney; Male; Natriuretic Peptide, Brain; Sympathectomy; Time Factors; Transforming Growth Factor beta; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling	2014
Osteopontin-CD44v6 interaction mediates calcium deposition via phospho-Akt in valve interstitial cells from patients with noncalcified aortic valve sclerosis. Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:9 Topics: Angiotensin II; Animals; Aortic Valve; Aortic Valve Stenosis; Bioreactors; Bone Morphogenetic Protein 4; Calcinosis; Calcium; Cell Transdifferentiation; Disease Models, Animal; Disease Progression; Humans; Hyaluronan Receptors; Male; Mice; Mice, Inbred C57BL; Osteogenesis; Osteopontin; Phosphorylation; Protein Interaction Mapping; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Signal Transduction	2014
Renal expression of advanced oxidative protein products predicts progression of renal fibrosis in patients with IgA nephropathy. Laboratory investigation; a journal of technical methods and pathology, 2014, Volume: 94, Issue:9 Topics: Adult; Advanced Oxidation Protein Products; Angiotensin II; Biopsy; Disease Progression; Female; Fibrosis; Glomerulonephritis, IGA; Humans; Kidney Tubules; Male; Prospective Studies; Transforming Growth Factor beta1	2014
Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade. Kidney international, 2015, Volume: 87, Issue:2 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Proliferation; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Male; Mesangial Cells; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Valsartan; Vascular Endothelial Growth Factor A	2015
Role of two types of angiotensin II receptors in colorectal carcinoma progression. Pathobiology : journal of immunopathology, molecular and cellular biology, 2014, Volume: 81, Issue:4 Topics: Aged; Angiotensin II; Animals; Cell Line, Tumor; Colorectal Neoplasms; Disease Progression; Female; Gene Knockout Techniques; Humans; Liver Neoplasms; Male; Mice; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2014
5-Lipoxygenase pathway in experimental abdominal aortic aneurysms. Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:12 Topics: Aged; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Arachidonate 5-Lipoxygenase; Bone Marrow Transplantation; Disease Models, Animal; Disease Progression; Humans; Hypercholesterolemia; Lipoxygenase Inhibitors; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Neutrophil Infiltration; Pancreatic Elastase; Receptors, LDL; Signal Transduction; Transplantation Chimera	2014
Pharmacological inhibitor of notch signaling stabilizes the progression of small abdominal aortic aneurysm in a mouse model. Journal of the American Heart Association, 2014, Oct-27, Volume: 3, Issue:6 Topics: Aged; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Cell Differentiation; Cells, Cultured; Collagen; Dipeptides; Disease Models, Animal; Disease Progression; Elastin; Gene Expression Regulation; Humans; Macrophages; Male; Matrix Metalloproteinases; Mice, Knockout; Middle Aged; Receptor, Notch1; Signal Transduction; Time Factors; Transforming Growth Factor beta2	2014
A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse. Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:2 Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Cytokines; Disease Models, Animal; Disease Progression; Elastin; Inflammation Mediators; Injections, Intraperitoneal; Male; Mice, Knockout; Peptides; Phosphorylation; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Smad2 Protein; Smad3 Protein; Thrombospondin 1; Time Factors; Transforming Growth Factor beta1	2015
Imaging vessel wall biology to predict outcome in abdominal aortic aneurysm. Circulation. Cardiovascular imaging, 2015, Volume: 8, Issue:1 Topics: Angiotensin II; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Aortography; Biomarkers; Disease Models, Animal; Disease Progression; Enzyme Activation; Feasibility Studies; Male; Matrix Metalloproteinases; Mice, Inbred C57BL; Mice, Transgenic; Molecular Imaging; Multimodal Imaging; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Risk Factors; Time Factors; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2015
Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation. Acta neuropathologica communications, 2015, Feb-03, Volume: 3 Topics: Aged; Aged, 80 and over; Angiotensin II; Case-Control Studies; Caspase 3; Disease Progression; Dopaminergic Neurons; Female; Guanosine; Humans; Male; NADPH Oxidases; Oxidative Stress; Parkinson Disease; Receptor, Angiotensin, Type 1; Substantia Nigra	2015
ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression. Thrombosis and haemostasis, 2015, Volume: 113, Issue:6 Topics: Aged; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoprotein A-I; Apolipoproteins E; Biomarkers; Cholesterol, HDL; Chromatography, Liquid; Denmark; Disease Models, Animal; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Humans; Linear Models; Male; Mice, Inbred C57BL; Mice, Knockout; Molecular Mimicry; Multivariate Analysis; Nanotechnology; Peptides; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Proteomics; Registries; Spain; Tandem Mass Spectrometry	2015
Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula. Clinical and experimental pharmacology & physiology, 2015, Volume: 42, Issue:7 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Cytochrome P-450 Enzyme System; Disease Progression; Enzyme Inhibitors; Epoxide Hydrolases; Fatty Acids, Monounsaturated; Female; Fistula; Heart Failure; Heart Rate; Hemodynamics; Kidney; Male; Peptide Fragments; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; Solubility; Time Factors; Vena Cava, Inferior	2015
Elevated Endothelial Hypoxia-Inducible Factor-1α Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney Disease. Hypertension (Dallas, Tex. : 1979), 2015, Volume: 66, Issue:1 Topics: Angiotensin II; Animals; Antigens, CD; Cadherins; Cells, Cultured; Disease Progression; Endothelial Cells; Endothelin-1; Endothelium, Vascular; Feedback, Physiological; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Glomerulus; Mice; Mice, Transgenic; NF-kappa B; Organ Culture Techniques; Renal Insufficiency, Chronic; RNA, Small Interfering; Up-Regulation	2015
Development of a Model of Chronic Kidney Disease in the C57BL/6 Mouse with Properties of Progressive Human CKD. BioMed research international, 2015, Volume: 2015 Topics: Angiotensin II; Animals; Desoxycorticosterone Acetate; Disease Models, Animal; Disease Progression; Female; Humans; Male; Mice; Renal Insufficiency, Chronic	2015
Morphological and Biomechanical Differences in the Elastase and AngII apoE(-/-) Rodent Models of Abdominal Aortic Aneurysms. BioMed research international, 2015, Volume: 2015 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Biomechanical Phenomena; Blood Flow Velocity; Blood Pressure; Disease Models, Animal; Disease Progression; Humans; Mice; Mice, Knockout; Pancreatic Elastase; Rats	2015
Effects of long-term chloroquine administration on the natural history of aortic aneurysms in mice. Canadian journal of physiology and pharmacology, 2015, Volume: 93, Issue:8 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Autophagy; Chloroquine; Collagen; Disease Models, Animal; Disease Progression; Elastin; Male; Mice, Inbred C57BL; Mice, Knockout; Time Factors	2015
Th-17 cell activation in response to high salt following acute kidney injury is associated with progressive fibrosis and attenuated by AT-1R antagonism. Kidney international, 2015, Volume: 88, Issue:4 Topics: Acute Kidney Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cells, Cultured; Cytoprotection; Disease Models, Animal; Disease Progression; Fibrosis; Kidney; Losartan; Lymphocyte Activation; Male; Nephrectomy; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Renin-Angiotensin System; Sodium Chloride, Dietary; Th17 Cells; Time Factors	2015
Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice. Endocrinology, 2015, Volume: 156, Issue:12 Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cell Line, Tumor; Cell Membrane; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Progression; Insulin-Secreting Cells; Insulinoma; Islets of Langerhans; Male; Mice; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Rats; RNA, Messenger	2015
Chronic Activation of the Renin-Angiotensin System Induces Lung Fibrosis. Scientific reports, 2015, Oct-23, Volume: 5 Topics: Angiotensin II; Animals; Disease Progression; Hypertension; Mice; Mice, Transgenic; Pulmonary Fibrosis; Receptor, Angiotensin, Type 2; Renin-Angiotensin System	2015
Allergic Lung Inflammation Aggravates Angiotensin II-Induced Abdominal Aortic Aneurysms in Mice. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:1 Topics: Angiotensin II; Animals; Anti-Allergic Agents; Antibodies, Monoclonal; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Calcium Chloride; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Immunoglobulin E; Inflammation Mediators; Lung; Macrophages; Male; Mast Cells; Mice, Inbred C57BL; Mice, Knockout; Ovalbumin; Pneumonia; Respiratory Hypersensitivity; Risk Factors; Signal Transduction; Vascular Remodeling	2016
Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:3 Topics: Administration, Intravenous; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Brachiocephalic Trunk; Cardiovascular Agents; Cathepsins; Cell Differentiation; Cells, Cultured; Chemistry, Pharmaceutical; Cytokines; Diet, High-Fat; Disease Models, Animal; Disease Progression; Drug Carriers; Inflammation Mediators; Lactic Acid; Macrophages, Peritoneal; Male; Matrix Metalloproteinases; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Nanoparticles; Phenotype; Pioglitazone; Plaque, Atherosclerotic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rupture, Spontaneous; Thiazolidinediones	2016
Ascending Aortic Aneurysm in Angiotensin II-Infused Mice: Formation, Progression, and the Role of Focal Dissections. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:4 Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Aortic Dissection; Aortic Rupture; Aortic Valve Insufficiency; Aortography; Apolipoproteins E; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Elastic Tissue; Male; Mice, Inbred C57BL; Mice, Knockout; Time Factors; Ultrasonography, Doppler, Pulsed; Vascular Remodeling; X-Ray Microtomography	2016
Transient Receptor Potential Melastatin 7 Cation Channel Kinase: New Player in Angiotensin II-Induced Hypertension. Hypertension (Dallas, Tex. : 1979), 2016, Volume: 67, Issue:4 Topics: Analysis of Variance; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Hypertension; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Random Allocation; Reactive Oxygen Species; Risk Assessment; TRPM Cation Channels; Up-Regulation; Ventricular Dysfunction, Left	2016
Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors. Disease models & mechanisms, 2016, 05-01, Volume: 9, Issue:5 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Biomarkers; Collagen; Disease Models, Animal; Disease Progression; Elastin; Enzyme Induction; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Inflammation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Severity of Illness Index; Up-Regulation	2016
Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation. Kidney international, 2016, Volume: 89, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; CD36 Antigens; Chemokine CXCL1; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Fibrosis; Fluorescent Dyes; HeLa Cells; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-1beta; Interleukin-6; Kidney; Male; Mice, Inbred C57BL; Mice, Knockout; Nephrectomy; NLR Family, Pyrin Domain-Containing 3 Protein; Peptides; Renal Insufficiency, Chronic; Ureteral Obstruction	2016
Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells. International journal of oncology, 2016, Volume: 48, Issue:6 Topics: Angiotensin II; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Metastasis; Prostatic Neoplasms; Relaxin; Signal Transduction; Survivin	2016
The kinetics of angiotensin-I metabolism in human carotid atheroma: An emerging role for angiotensin (1-7). Vascular pharmacology, 2016, Volume: 85 Topics: Angiotensin I; Angiotensin II; Angiotensin III; Carotid Artery Diseases; Chromatography, High Pressure Liquid; Disease Progression; Humans; Mass Spectrometry; Peptide Fragments; Plaque, Atherosclerotic; Time Factors	2016
Biomechanical Strain Exacerbates Inflammation on a Progeria-on-a-Chip Model. Small (Weinheim an der Bergstrasse, Germany), 2017, Volume: 13, Issue:15 Topics: Angiotensin II; Biomechanical Phenomena; Blood Vessels; Cytoskeleton; Disease Progression; Humans; Induced Pluripotent Stem Cells; Inflammation; Lab-On-A-Chip Devices; Lovastatin; Microfluidics; Myocytes, Smooth Muscle; Phenotype; Progeria	2017
Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2008, Volume: 9, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Immunohistochemistry; Irbesartan; Kidney Glomerulus; Male; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2008
Gene targeting and heme oxygenase-1 expression in prevention of hypertension induced by angiotensin II. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Disease Progression; Gene Targeting; Heme Oxygenase-1; Hypertension, Renovascular; Mice; Mice, Inbred C57BL; Rats; Vasoconstrictor Agents	2008
Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta neurologica Scandinavica, 2009, Volume: 119, Issue:5 Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Angiotensin II; Biomarkers; Cerebrospinal Fluid Proteins; Cytoprotection; Disease Progression; Down-Regulation; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Receptor, Angiotensin, Type 2; Severity of Illness Index; Spinal Cord; Spinocerebellar Degenerations	2009
Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan. International journal of molecular medicine, 2008, Volume: 22, Issue:6 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Pressure; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neutrophil Infiltration; NF-kappa B; Pancreatic Elastase; Rats; Rats, Wistar; Tetrazoles; Ultrasonography; Valine; Valsartan	2008
Conventional therapy with an ACE inhibitor diminishes left ventricular dyssynchrony during the progression of heart failure. International journal of cardiology, 2010, Apr-01, Volume: 140, Issue:1 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Comorbidity; Disease Progression; Dogs; Heart Failure; Hemodynamics; Male; Norepinephrine; Ventricular Dysfunction, Left	2010
Decreased expression of angiotensin-converting enzyme 2 in pancreatic ductal adenocarcinoma is associated with tumor progression. The Tohoku journal of experimental medicine, 2009, Volume: 217, Issue:2 Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme 2; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Disease Progression; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Middle Aged; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Protein Transport; RNA Interference	2009
Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:5 Topics: Angiotensin II; Animals; Arginine Vasopressin; Butadienes; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Male; MAP Kinase Kinase Kinases; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitriles; Nitroarginine; Nitroprusside; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Piperidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Vasoconstriction; Vasodilation	2009
Impact of early onset obesity and hypertension on the unfolded protein response in renal tissues of juvenile sheep. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 53, Issue:6 Topics: Analysis of Variance; Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Disease Models, Animal; Disease Progression; Female; Hypertension; Immunohistochemistry; Kidney; Kidney Diseases; Male; Nitric Oxide; Obesity; Proteins; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Sheep; Statistics, Nonparametric; Tissue Culture Techniques	2009
Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin. International journal of oncology, 2009, Volume: 34, Issue:6 Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Carcinoma, Medullary; Case-Control Studies; Cell Proliferation; Disease Progression; Electrophoretic Mobility Shift Assay; Female; Gastric Mucosa; Humans; Immunoenzyme Techniques; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Peritoneal Neoplasms; Receptor, Angiotensin, Type 1; Stomach; Stomach Neoplasms; Survival Rate; Survivin; Tetrazoles; Tumor Cells, Cultured	2009
Chymase activity is closely related with plaque vulnerability in a hamster model of atherosclerosis. Atherosclerosis, 2009, Volume: 207, Issue:1 Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Apoptosis; Atherosclerosis; Body Weight; Cell Degranulation; Cholesterol; Chymases; Cricetinae; Disease Models, Animal; Disease Progression; Immunohistochemistry; Inflammation; Inflammation Mediators; Lipids; Male; Mast Cells; Mesocricetus; Microscopy, Electron, Transmission; ortho-Aminobenzoates; Ovalbumin; Peptidyl-Dipeptidase A; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rupture; Time Factors; Ultrasonography, Doppler, Duplex	2009
Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II- infused ApoE-deficient mice. Journal of atherosclerosis and thrombosis, 2009, Volume: 16, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Benzimidazoles; Biphenyl Compounds; Chymases; Disease Progression; Lisinopril; Mice; Mice, Knockout; Peptidyl-Dipeptidase A; Tetrazoles	2009
Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension. Journal of hypertension, 2009, Volume: 27, Issue:10 Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Disease Progression; Hypertension, Renovascular; Infusion Pumps, Implantable; Peptide Fragments; Rats; Rats, Transgenic; Surgical Instruments; Telemetry; Vasodilator Agents	2009
Contribution of chymase-dependent angiotensin II formation to the progression of tubulointerstitial fibrosis in obstructed kidneys in hamsters. Journal of pharmacological sciences, 2009, Volume: 111, Issue:1 Topics: Actins; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Blood Urea Nitrogen; Butyrates; Chymases; Collagen Type I; Cricetinae; Disease Progression; Imidazoles; Kidney; Male; Mesocricetus; Nephritis, Interstitial; Organ Size; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Transforming Growth Factor beta; Ureteral Obstruction	2009
A role of matrix metalloproteinase-8 in atherosclerosis. Circulation research, 2009, Oct-23, Volume: 105, Issue:9 Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Carotid Artery Diseases; Collagen; Coronary Stenosis; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Gene Frequency; Genetic Predisposition to Disease; Humans; Leukocyte Rolling; Macrophages; Male; Matrix Metalloproteinase 8; Mice; Mice, Knockout; Polymorphism, Single Nucleotide; Prospective Studies; Severity of Illness Index; Vascular Cell Adhesion Molecule-1	2009
ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis. American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:1 Topics: Angiotensin II; Animals; Cell Survival; Cells, Cultured; Collagen; Disease Models, Animal; Disease Progression; Extracellular Matrix; Glomerulonephritis; Hydrogen Peroxide; Mesangial Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 7; Phosphorylation; Rats; Rats, Inbred Strains	2010
Matrix metalloproteinase-8 and the regulation of blood pressure, vascular inflammation, and atherosclerotic lesion growth. Circulation research, 2009, Oct-23, Volume: 105, Issue:9 Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Blood Pressure; Disease Models, Animal; Disease Progression; Humans; Inflammation; Matrix Metalloproteinase 8; Mice; Mice, Knockout; Vascular Cell Adhesion Molecule-1	2009
Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes, 2010, Volume: 59, Issue:2 Topics: Actins; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Coagulation; Blood Glucose; Blood Pressure; Collagen; Diabetic Nephropathies; Disease Progression; Heparin; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Peptidyl-Dipeptidase A; Recombinant Proteins; RNA, Messenger	2010
Pharmacological inhibition of BLT1 diminishes early abdominal aneurysm formation. Atherosclerosis, 2010, Volume: 210, Issue:1 Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Benzopyrans; Carboxylic Acids; Chemotaxis; Disease Progression; Immunohistochemistry; Leukotriene B4; Male; Mice; Ultrasonography	2010
TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. The Journal of clinical investigation, 2010, Volume: 120, Issue:2 Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Aneurysm, Abdominal; Disease Progression; Inflammation; Male; Matrix Metalloproteinase 12; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Transforming Growth Factor beta; Ultrasonography	2010
Lymphocyte responses exacerbate angiotensin II-dependent hypertension. American journal of physiology. Regulatory, integrative and comparative physiology, 2010, Volume: 298, Issue:4 Topics: Angiotensin II; Animals; Body Weight; Cardiomegaly; Crosses, Genetic; Disease Progression; Heart; Hemodynamics; Hypertension; Kidney; Lymphocytes; Mice; Mice, Inbred C3H; Mice, SCID; Organ Size; RNA, Messenger	2010
Cellular phenotype transformation occurs during thoracic aortic aneurysm development. The Journal of thoracic and cardiovascular surgery, 2010, Volume: 140, Issue:3 Topics: Angiotensin II; Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Calcium Chloride; Cells, Cultured; Disease Models, Animal; Disease Progression; Endothelin-1; Extracellular Matrix Proteins; Female; Fibroblasts; Gene Expression Profiling; Gene Expression Regulation; Genotype; Male; Mice; Mice, Inbred C57BL; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Tetradecanoylphorbol Acetate	2010
Weight loss in obese C57BL/6 mice limits adventitial expansion of established angiotensin II-induced abdominal aortic aneurysms. American journal of physiology. Heart and circulatory physiology, 2010, Volume: 298, Issue:6 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Connective Tissue; Dietary Fats; Disease Models, Animal; Disease Progression; Endoglin; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Obesity; RNA, Messenger; Weight Loss	2010
Renin-angiotensin system activation in congenital hepatic fibrosis in the PCK rat model of autosomal recessive polycystic kidney disease. Journal of pediatric gastroenterology and nutrition, 2010, Volume: 50, Issue:6 Topics: Angiotensin II; Animals; Collagen; Disease Models, Animal; Disease Progression; Gene Expression; Liver; Liver Cirrhosis; Male; Peptidyl-Dipeptidase A; Polycystic Kidney, Autosomal Recessive; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Transforming Growth Factor beta	2010
Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:8 Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Superoxides; Time Factors; Vasodilation; Vasodilator Agents	2010
Role of the renin-angiotensin system in cardiovascular disease. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Disease Progression; Environment; Genetic Predisposition to Disease; Humans; Medication Therapy Management; Receptors, Angiotensin; Renin; Renin-Angiotensin System	2010
Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice. Journal of vascular surgery, 2010, Volume: 52, Issue:1 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Body Weight; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Gene Expression Regulation, Enzymologic; Humans; Infusion Pumps, Implantable; Injections, Intraperitoneal; Magnetic Resonance Angiography; Male; Matrix Metalloproteinase 2; Mice; Mice, Knockout; Recombinant Proteins; Time Factors; Vascular Endothelial Growth Factor A	2010
Hyperglycemia limits experimental aortic aneurysm progression. Journal of vascular surgery, 2010, Volume: 52, Issue:4 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Progression; Hypoglycemic Agents; Insulin; Macrophages; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Pancreatic Elastase; Peritonitis; Thioglycolates; Time Factors; Ultrasonography; Vascular Endothelial Growth Factor A	2010
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney international, 2010, Volume: 78, Issue:11 Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Desoxycorticosterone; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Glomerulonephritis; Heart Diseases; Hydralazine; Hypertension; Imidazoles; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Kidney Diseases; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nephrectomy; Sodium Chloride, Dietary; Species Specificity; Telemetry; Tetrazoles; Time Factors; X-Ray Microtomography	2010
The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease. Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:12 Topics: Aging; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Hypertension; Kidney; Male; Mutation; Peptidyl-Dipeptidase A; Polycystic Kidney, Autosomal Recessive; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Time Factors	2010
Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells. International journal of oncology, 2010, Volume: 37, Issue:5 Topics: Angiotensin II; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blotting, Western; Cholangiocarcinoma; Disease Progression; Fibrosis; Glial Fibrillary Acidic Protein; Hepatic Stellate Cells; Humans; Immunohistochemistry; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction	2010
Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease. The European journal of neuroscience, 2010, Volume: 32, Issue:10 Topics: Adrenergic Uptake Inhibitors; Angiotensin II; Animals; Corpus Striatum; Disease Progression; Dopamine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Reserpine; Substantia Nigra	2010
Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms. Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:2 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Biomechanical Phenomena; Blood Pressure; Disease Progression; Elastin; Hypertension; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Animal; Models, Cardiovascular; Ultrasonography	2011
Knockout of angiotensin 1-7 receptor Mas worsens the course of two-kidney, one-clip Goldblatt hypertension: roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II. Kidney & blood pressure research, 2010, Volume: 33, Issue:6 Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Disease Progression; Hypertension, Renovascular; Male; Mice; Mice, Knockout; Nitric Oxide; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Surgical Instruments; Vasomotor System	2010
The frail renin-angiotensin system. Clinics in geriatric medicine, 2011, Volume: 27, Issue:1 Topics: Aged; Aging; Angiotensin II; Apoptosis; Disease Progression; Frail Elderly; Humans; Hypertension; Inflammation; Oxidative Stress; Reactive Oxygen Species; Receptors, Angiotensin; Renin-Angiotensin System	2011
Involvement of activated prorenin in the pathogenesis of slowly progressive nephropathy in the non-clipped kidney of two kidney, one-clip hypertension. Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:3 Topics: Angiotensin II; Animals; Disease Progression; Hypertension, Renovascular; Kidney Diseases; Male; Oligopeptides; Rats; Rats, Sprague-Dawley; Renin; Transforming Growth Factor beta	2011
Underuse of ACE inhibitors and angiotensin II receptor blockers among patients with diabetic nephropathy in Taiwan. Health policy (Amsterdam, Netherlands), 2011, Volume: 100, Issue:2-3 Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cohort Studies; Databases as Topic; Diabetic Nephropathies; Disease Progression; Female; Guideline Adherence; Humans; Hypertension; Male; Middle Aged; Practice Patterns, Physicians'; Proteinuria; Taiwan; Vasoconstrictor Agents	2011
Impact of polymorphisms of the genes encoding angiotensin II-forming enzymes on the progression of IgA nephropathy. Nephron. Clinical practice, 2011, Volume: 118, Issue:2 Topics: Adult; Angiotensin II; Asian People; Chymases; Disease Progression; Female; Follow-Up Studies; Gene Frequency; Glomerulonephritis, IGA; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Renin; Young Adult	2011
[The role of renin-angiotensin system independent angiotensin II production in progression and fibrosis of intrahepatic cholangiocarcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Disease Progression; Fibrosis; Hepatic Stellate Cells; Humans; Receptor, Angiotensin, Type 1; Telmisartan	2010
Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Progression; Glomerulosclerosis, Focal Segmental; Hypertension; Imidazoles; Kidney; Kidney Diseases; Male; NF-E2 Transcription Factor; NF-kappa B; Oxidative Stress; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Tetrazoles; Thiobarbituric Acid Reactive Substances	2011
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats. American journal of physiology. Gastrointestinal and liver physiology, 2011, Volume: 300, Issue:6 Topics: Administration, Oral; Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzoates; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Choline Deficiency; Deferasirox; Disease Progression; Drug Therapy, Combination; Fatty Liver; Hepatic Stellate Cells; Iron Chelating Agents; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Losartan; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Inbred F344; Time Factors; Transforming Growth Factor beta1; Triazoles	2011
Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science (New York, N.Y.), 2011, Apr-15, Volume: 332, Issue:6027 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm; Aortic Rupture; Disease Models, Animal; Disease Progression; Enalapril; Losartan; MAP Kinase Signaling System; Marfan Syndrome; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptor, Angiotensin, Type 2; Signal Transduction; Transforming Growth Factor beta	2011
Angiotensin-II mediates nonmuscle myosin II activation and expression and contributes to human keloid disease progression. Molecular medicine (Cambridge, Mass.), 2011, Volume: 17, Issue:11-12 Topics: Adolescent; Adult; Angiotensin II; Cell Movement; Cell Proliferation; Dermis; Disease Progression; Female; Fibroblasts; Humans; Immunohistochemistry; Keloid; Male; Middle Aged; Molecular Motor Proteins; Myosin Heavy Chains; Nonmuscle Myosin Type IIB; Protein Isoforms; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Young Adult	2011
Role of AT₁ receptor-mediated salt retention in angiotensin II-dependent hypertension. American journal of physiology. Renal physiology, 2011, Volume: 301, Issue:5 Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Diet, Sodium-Restricted; Disease Progression; Hypertension, Renal; Kidney; Kidney Transplantation; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Receptor, Angiotensin, Type 1; Salts	2011
Comparison of ROCK and EGFR activation pathways in the progression of glomerular injuries in AngII-infused rats. Renal failure, 2011, Volume: 33, Issue:10 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Disease Progression; ErbB Receptors; Gefitinib; Kidney Diseases; Kidney Glomerulus; Male; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Wistar; rho-Associated Kinases; Signal Transduction	2011
Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage. Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:1 Topics: Adult; Angiotensin II; Animals; Biopsy; Blood Pressure; Disease Progression; Endothelin-1; Female; Fibrosis; Humans; Hypertension, Renal; Interleukin-6; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Middle Aged; Organ Culture Techniques; Proteinuria; Renal Insufficiency, Chronic; Signal Transduction; Vasoconstrictor Agents	2012
Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. The Journal of clinical investigation, 2012, Volume: 122, Issue:2 Topics: Adolescent; Aged; Aneurysm, Ruptured; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Collagen; Disease Models, Animal; Disease Progression; Elastin; Gene Expression; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Middle Aged; Pancreatic Elastase; Protein Isoforms; Swine; Young Adult	2012
Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE⁻/⁻ mice. Cardiovascular research, 2012, Apr-01, Volume: 94, Issue:1 Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Chemotaxis; Disease Models, Animal; Disease Progression; Endothelial Cells; Humans; Macrophages; Membrane Glycoproteins; Mice; Mice, Knockout; Mice, Transgenic; NADPH Oxidase 2; NADPH Oxidases; Signal Transduction; Superoxides; Time Factors; Up-Regulation; Vascular Cell Adhesion Molecule-1	2012
Persistent oxidative stress following renal ischemia-reperfusion injury increases ANG II hemodynamic and fibrotic activity. American journal of physiology. Renal physiology, 2012, Jun-01, Volume: 302, Issue:11 Topics: Acetophenones; Acute Kidney Injury; Angiotensin II; Animals; Blood Pressure; Creatinine; Disease Progression; Dose-Response Relationship, Drug; Fibrosis; Hemodynamics; Immunohistochemistry; Kidney; Kidney Failure, Chronic; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Renal Circulation; Reperfusion Injury; RNA, Messenger; Vasoconstrictor Agents	2012
Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice. Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:6 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Atherosclerosis; Carotid Artery Diseases; Carotid Artery, Common; CD36 Antigens; Disease Models, Animal; Disease Progression; Focal Adhesion Kinase 1; Gene Deletion; JNK Mitogen-Activated Protein Kinases; Lipids; Lipoproteins, LDL; Macrophages; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Plaque, Atherosclerotic; Receptor, Angiotensin, Type 1; Rupture, Spontaneous; Superoxides; Tetrazoles; Time Factors; Valine; Valsartan	2012
Angiotensin II plays a critical role in alcohol-induced cardiac nitrative damage, cell death, remodeling, and cardiomyopathy in a protein kinase C/nicotinamide adenine dinucleotide phosphate oxidase-dependent manner. Journal of the American College of Cardiology, 2012, Apr-17, Volume: 59, Issue:16 Topics: Angiotensin II; Animals; Cardiomyopathy, Alcoholic; Cell Death; Disease Models, Animal; Disease Progression; Ethanol; Heart Ventricles; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NADP; Oxidative Stress; Protein Kinase C; Ventricular Remodeling	2012
Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. The American journal of pathology, 2012, Volume: 181, Issue:2 Topics: Angiotensin II; Animals; Aorta; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Apoptosis; Azo Compounds; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Endothelial Cells; Fenofibrate; Inflammation; Kidney; Lipoproteins, HDL; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Receptors, Lysosphingolipid; Sphingosine; Treatment Outcome; Up-Regulation	2012
Group V secretory phospholipase A2 enhances the progression of angiotensin II-induced abdominal aortic aneurysms but confers protection against angiotensin II-induced cardiac fibrosis in apoE-deficient mice. The American journal of pathology, 2012, Volume: 181, Issue:3 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Aortic Rupture; Apolipoproteins E; Apoptosis; Collagen; Disease Progression; Fibrosis; Group V Phospholipases A2; Immunohistochemistry; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Prostaglandins	2012
Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotype. Journal of cardiovascular pharmacology, 2012, Volume: 60, Issue:6 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Biomarkers; Celecoxib; Cell Differentiation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenotype; Pyrazoles; RNA, Messenger; Severity of Illness Index; Sulfonamides; Time Factors	2012
Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression. Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:4 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Cells, Cultured; Chemokine CCL5; Chemotaxis, Leukocyte; Disease Models, Animal; Disease Progression; Injections, Intravenous; Leukocytes; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Smooth Muscle; Oligopeptides; Pancreatic Elastase; Platelet Factor 4; Receptors, CCR5; Time Factors	2013
Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis. Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Communication; Disease Models, Animal; Disease Progression; DNA Primers; Dose-Response Relationship, Drug; Fatty Liver; Gene Expression; Hepatic Stellate Cells; Liver Cirrhosis; Losartan; Male; NF-kappa B; Non-alcoholic Fatty Liver Disease; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Toll-Like Receptor 4; Transforming Growth Factor beta	2013
Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney international, 2002, Volume: 62, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Body Weight; Collagen Type III; Disease Progression; Kidney Diseases; Kidney Glomerulus; Lisinopril; Macrophages; Male; Monocytes; Proteinuria; Rats; Rats, Wistar; Renal Circulation; Tetrazoles; Valine; Valsartan	2002
L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. American journal of physiology. Cell physiology, 2002, Volume: 283, Issue:3 Topics: Angiotensin II; Animals; Apoptosis; Carnitine; Caspase 3; Caspase 9; Caspases; Cell Nucleus; Cells, Cultured; Cytoprotection; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Glucose Transporter Type 4; Heart Failure; In Situ Nick-End Labeling; Liver Function Tests; Male; Monocrotaline; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Muscular Disorders, Atrophic; Myosin Heavy Chains; Protein Isoforms; Rats; Rats, Sprague-Dawley; Sphingolipids; Staurosporine; Tumor Necrosis Factor-alpha	2002
Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta. Journal of molecular and cellular cardiology, 2002, Volume: 34, Issue:10 Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Progression; Echocardiography; Enzyme Activation; Heart Failure; Hypertension; Male; Myocardium; Organ Size; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-epsilon; Protein Transport; Rats; Rats, Inbred Dahl; Stress, Mechanical; Tetrazoles; Valine; Valsartan; Ventricular Function, Left	2002
Tonin in rat heart with experimental hypertrophy. American journal of physiology. Heart and circulatory physiology, 2003, Volume: 284, Issue:6 Topics: Adrenergic beta-Agonists; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Disease Progression; Gene Expression Regulation; Isoproterenol; Male; Myocardium; Organ Size; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA Probes; Tissue Kallikreins	2003
Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation, 2003, May-27, Volume: 107, Issue:20 Topics: Angiotensin II; Animals; Chymases; Collagen Type I; Collagen Type III; Diastole; Disease Models, Animal; Disease Progression; Dogs; Enzyme Inhibitors; Fibrosis; Heart Failure; Hemodynamics; Mast Cells; Myocardium; Peptidyl-Dipeptidase A; RNA, Messenger; Serine Endopeptidases; Transforming Growth Factor beta; Ventricular Dysfunction, Left	2003
Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation, 2003, Oct-28, Volume: 108, Issue:17 Topics: Angiotensin II; Animals; Chemokine CCL2; Cytokines; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Genetic Therapy; Heart Failure; Humans; Immunohistochemistry; Male; Matrix Metalloproteinases; Mice; Muscle, Skeletal; Myocardial Infarction; Myocardium; Sequence Deletion; Survival Rate; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Ventricular Remodeling	2003
Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circulation research, 2003, Oct-31, Volume: 93, Issue:9 Topics: Angiotensin II; Animals; Aorta; Bacterial Proteins; Blood Pressure; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Disease Progression; Hypertension; Isoenzymes; Male; Membrane Glycoproteins; Mice; Mice, Knockout; Myocardium; NADH, NADPH Oxidoreductases; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species	2003
Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. Circulation research, 2003, Oct-31, Volume: 93, Issue:9 Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Body Weight; Cardiomegaly; Coronary Vessels; Disease Models, Animal; Disease Progression; Fibrosis; Gene Expression; Heart Rate; Infusion Pumps, Implantable; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; Receptor, Angiotensin, Type 1; Superoxides; Ventricular Remodeling	2003
The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises. Kidney international, 2003, Volume: 64, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Clinical Trials as Topic; Disease Progression; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney Diseases; Kidney Glomerulus; Proteinuria	2003
Stenosis progression after surgical injury in Milan hypertensive rat carotid arteries. Cardiovascular research, 2003, Dec-01, Volume: 60, Issue:3 Topics: Angiotensin I; Angiotensin II; Animals; Apoptosis; Carotid Arteries; Carotid Stenosis; Disease Progression; Gene Expression; Genes, fos; Genes, jun; Genes, myc; Hypertension; Models, Animal; Rats; Rats, Inbred Strains; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger	2003
Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury. Kidney international, 2004, Volume: 65, Issue:2 Topics: Angiotensin II; Animals; Apoptosis; Cells, Cultured; Creatinine; Disease Progression; Epithelial Cells; Extracellular Matrix; Fibroblasts; Hepatocyte Growth Factor; Humans; Kidney Tubules, Proximal; Male; Matrix Metalloproteinase 9; Nephritis, Interstitial; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-2; Vasoconstrictor Agents	2004
Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice. Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Chemokine CCL2; Chemokines; Cytokines; Disease Progression; Gene Expression Regulation; Gene Targeting; Humans; Hyperlipoproteinemia Type II; Imidazoles; Inflammation; Inflammation Mediators; Injections, Intramuscular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Olmesartan Medoxomil; Random Allocation; Recombinant Fusion Proteins; Sequence Deletion; Single-Blind Method; Tetrazoles	2004
How does angiotensin II cause renal injury? Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Disease Progression; Humans; Hypertension; Hypertension, Renal; Kidney Diseases; Kidney Glomerulus; Models, Biological; Peptidyl-Dipeptidase A; Rats; Renal Circulation; Renal Insufficiency; Renin-Angiotensin System; Vasoconstriction	2004
Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. Journal of the American Society of Nephrology : JASN, 2004, Volume: 15, Issue:6 Topics: Angiotensin II; Animals; Disease Progression; Gene Expression Regulation; Genotype; Immunohistochemistry; Inflammation; Kidney; Kidney Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA; Time Factors; Up-Regulation; Ureteral Obstruction	2004
Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II. The British journal of ophthalmology, 2004, Volume: 88, Issue:8 Topics: Adult; Aged; Angiotensin II; Diabetic Retinopathy; Disease Progression; Female; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Vitreous Body	2004
Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circulation research, 2004, Sep-03, Volume: 95, Issue:5 Topics: Angiotensin II; Animals; Animals, Genetically Modified; Cardiac Output, Low; Cardiomyopathies; Collagenases; Disease Progression; Enzyme Precursors; Extracellular Matrix; Gelatinases; Gene Expression; Gene Expression Profiling; Genetic Predisposition to Disease; Heart Rupture; Humans; Hypertension; Hypertrophy, Left Ventricular; Matrix Metalloproteinase 9; Metalloendopeptidases; Mice; Mice, Knockout; Myocardium; Rats; Rats, Sprague-Dawley; Renin; Stroke Volume; Thrombospondins; Up-Regulation	2004
Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation, 2004, Aug-10, Volume: 110, Issue:6 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Valve Stenosis; Apoptosis; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Progression; Endoplasmic Reticulum; Gene Expression Regulation; Heart Failure; Humans; Imidazoles; Ligation; Male; Mice; Mice, Inbred C57BL; Molecular Chaperones; Myocytes, Cardiac; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Inbred WKY; RNA, Messenger; Signal Transduction; Stress, Physiological; Tetrazoles; Thapsigargin; Tunicamycin	2004
Vasoactive mediators and retinopathy during type 1 diabetic pregnancy. Acta ophthalmologica Scandinavica, 2005, Volume: 83, Issue:1 Topics: Adrenomedullin; Adult; Aldosterone; Angiotensin II; Blood Flow Velocity; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Disease Progression; Female; Glycated Hemoglobin; Humans; Natriuretic Peptides; Peptides; Pregnancy; Pregnancy in Diabetics; Renin; Renin-Angiotensin System; Retinal Vessels; Vasoconstrictor Agents; Vasodilator Agents	2005
Hypoxia-inducible factor-1alpha is involved in the attenuation of experimentally induced rat glomerulonephritis. Nephron. Experimental nephrology, 2005, Volume: 100, Issue:2 Topics: Angiotensin II; Animals; Cell Survival; Crotalid Venoms; Disease Models, Animal; Disease Progression; Glomerulonephritis; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Rats; Rats, Wistar; Trimeresurus	2005
Possible involvement of aminopeptidase A in hypertension and renal damage in Dahl salt-sensitive rats. American journal of hypertension, 2005, Volume: 18, Issue:4 Pt 1 Topics: Angiotensin II; Animals; Blood Pressure; Disease Progression; Dose-Response Relationship, Drug; Glomerulosclerosis, Focal Segmental; Glutamyl Aminopeptidase; Hyalin; Hypertension; Immunohistochemistry; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Rats; Rats, Inbred Dahl; Severity of Illness Index; Sodium Chloride, Dietary; Staining and Labeling	2005
Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation, 2005, Jun-14, Volume: 111, Issue:23 Topics: Adult; Aged; Angiotensin II; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis; Biopsy; Biphenyl Compounds; Cell Proliferation; Cells, Cultured; Disease Progression; Gene Expression Regulation, Enzymologic; Glycoproteins; Humans; Irbesartan; Male; Matrix Metalloproteinase 9; Middle Aged; Muscle, Smooth, Vascular; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Tetrazoles; Ultrasonography	2005
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy. American journal of hypertension, 2005, Volume: 18, Issue:7 Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiomegaly; Collagen; Disease Progression; Endothelium, Vascular; Heart Rate; Hypertension; Imidazoles; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles; Vascular Diseases; Vascular Resistance	2005
Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice. Toxicology and applied pharmacology, 2006, Apr-15, Volume: 212, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Disease Progression; Echocardiography; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Hypertrophy, Left Ventricular; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Organ Size; Peptides, Cyclic; Receptor, Endothelin A; Receptors, Aryl Hydrocarbon; RNA, Messenger	2006
Pitavastatin inhibits cardiac hypertrophy in a rat model of progressive renal injury. Journal of cardiovascular pharmacology, 2005, Volume: 46, Issue:4 Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Progression; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Kidney; Male; Myocytes, Cardiac; Nephrectomy; Phosphorylation; Quinolines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstrictor Agents	2005
Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension. Microvascular research, 2005, Volume: 70, Issue:3 Topics: Administration, Oral; Age Factors; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Benzimidazoles; Benzoates; Blotting, Western; Coronary Artery Disease; Disease Progression; DNA Primers; Endothelial Cells; Endothelium, Vascular; Female; Humans; Hypertension; Male; Microcirculation; Middle Aged; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Telmisartan; Time Factors; Up-Regulation	2005
Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis. Journal of surgical oncology, 2006, Jan-01, Volume: 93, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Chymases; Disease Progression; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mast Cells; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Serine Endopeptidases; Stomach Neoplasms	2006
Apolipoprotein E and progression of chronic kidney disease. JAMA, 2006, Jan-04, Volume: 295, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Apolipoproteins E; Chronic Disease; Disease Progression; Humans; Kidney Diseases; Risk Factors	2006
Increased vascular angiotensin II binding capacity and ET-1 release in young cardiomyopathic hamsters. Vascular pharmacology, 2006, Volume: 44, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Binding, Competitive; Cardiomyopathies; Cricetinae; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin-1; In Vitro Techniques; Losartan; Male; Mesocricetus; Peptides, Cyclic; Protein Binding; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Vasoconstriction; Vasoconstrictor Agents	2006
Effects of L/N-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats. Biological & pharmaceutical bulletin, 2006, Volume: 29, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; Disease Progression; Hemodynamics; Hypertension; Kidney; Kidney Cortex; Kidney Failure, Chronic; Kidney Function Tests; Male; Norepinephrine; Rats; Rats, Inbred Dahl; Renin; von Willebrand Factor	2006
Cardiac energy metabolism alterations in angiotensin II induced hypertrophy. Journal of molecular and cellular cardiology, 2006, Volume: 41, Issue:3 Topics: Angiotensin II; Animals; Disease Progression; Energy Metabolism; Fatty Acids; Heart Failure; Humans; Hypertrophy; Mice; Models, Biological; Myocardium; Oxygen	2006
Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis. Kidney international, 2006, Volume: 70, Issue:9 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Progression; Drug Implants; Female; Gene Expression Regulation; Glomerulonephritis; Isoantibodies; Kidney Glomerulus; Microcirculation; Nephrectomy; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents	2006
ACE inhibitor use and the long-term risk of renal failure in diabetics. Kidney international, 2006, Volume: 70, Issue:7 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Follow-Up Studies; Humans; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Tretinoin	2006
A 5-year-old girl with impaired renal function after autologous bone marrow transplantation. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 48, Issue:4 Topics: Angiotensin II; Biopsy; Bone Marrow Transplantation; Child, Preschool; Disease Progression; Female; Humans; Kidney Glomerulus; Renal Insufficiency; Transplantation, Autologous	2006
High prevalence of ACE DD genotype among north Indian end stage renal disease patients. BMC nephrology, 2006, Oct-17, Volume: 7 Topics: Adult; Angiotensin II; Antihypertensive Agents; Case-Control Studies; Creatinine; Disease Progression; Female; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; India; Kidney; Kidney Failure, Chronic; Male; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Prevalence; Renin-Angiotensin System	2006
Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease. Pediatric research, 2006, Volume: 60, Issue:6 Topics: Adolescent; Angiotensin I; Angiotensin II; Angiotensins; Case-Control Studies; Child; Child, Preschool; Cross-Sectional Studies; Disease Progression; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System	2006
Mast cell-derived cathepsin g: a possible role in the adverse remodeling of the failing human heart. The Journal of surgical research, 2007, Jun-15, Volume: 140, Issue:2 Topics: Adult; Aged; Angiotensin II; Cardiac Output, Low; Case-Control Studies; Cathepsin G; Cathepsins; Chymases; Disease Progression; Female; Heart-Assist Devices; Humans; Male; Mast Cells; Middle Aged; Myocardium; Necrosis; Serine Endopeptidases; Tryptases; Ventricular Remodeling	2007
Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. Journal of the American Society of Nephrology : JASN, 2007, Volume: 18, Issue:6 Topics: Age Factors; Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Chlorocebus aethiops; COS Cells; Disease Progression; Glomerulosclerosis, Focal Segmental; Humans; MAP Kinase Signaling System; Prorenin Receptor; Proteinuria; Rats; Receptors, Cell Surface; Transforming Growth Factor beta1	2007
Modification in the von Hippel-Lindau protein is involved in the progression of experimentally induced rat glomerulonephritis. Nephron. Experimental nephrology, 2007, Volume: 106, Issue:3 Topics: Angiotensin II; Animals; Cell Line; Disease Progression; Gene Expression Regulation; Glomerulonephritis; Humans; Kidney Glomerulus; Kidney Tubules; Male; Podocytes; Rats; Rats, Wistar; Snake Venoms; Thrombin; Trimeresurus; Von Hippel-Lindau Tumor Suppressor Protein	2007
The significance of chymase in the progression of abdominal aortic aneurysms in dogs. Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:4 Topics: Acetamides; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Cell Count; Chymases; Disease Models, Animal; Disease Progression; Dogs; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neutrophils; Pyrimidines; Tunica Media; Ultrasonography	2007
Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques. Journal of the American Society of Nephrology : JASN, 2007, Volume: 18, Issue:8 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Body Weight; Disease Progression; Elasticity; Female; Hydralazine; Lipids; Losartan; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Vasoconstrictor Agents	2007
Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension. The American journal of pathology, 2007, Volume: 171, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Disease Progression; Fibrosis; Glomerular Mesangium; Humans; Hypertension, Renal; Male; Matrix Metalloproteinase 2; Mice; Mice, Mutant Strains; Osteonectin; Rats; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta1	2007
Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2008, Volume: 12, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Disease Progression; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Genistein; Humans; Imidazoles; Immunohistochemistry; Losartan; Mitogen-Activated Protein Kinase 1; Neovascularization, Pathologic; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Signal Transduction; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents	2008
Potential benefit of angiotensin converting enzyme inhibitors for hindering progression of Graves' ophthalmopathy. Medical hypotheses, 2008, Volume: 70, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cytokines; Disease Progression; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Models, Biological; Models, Theoretical; Transforming Growth Factor beta; Treatment Outcome	2008
Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress. Cardiovascular research, 2008, Jun-01, Volume: 78, Issue:3 Topics: Angiogenic Proteins; Angiotensin II; Animals; Aorta, Thoracic; Apoptosis; Blotting, Western; Constriction; Disease Models, Animal; Disease Progression; Energy Metabolism; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Male; Mechanotransduction, Cellular; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; Neovascularization, Physiologic; Phosphorylation; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Stress, Mechanical; Ventricular Function, Left; Ventricular Remodeling	2008
Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:7 Topics: Adenoviridae; Angioplasty, Balloon; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta, Abdominal; Atherosclerosis; Cell Line; Cells, Cultured; Collagen; Diet, Atherogenic; Dietary Fats; Disease Models, Animal; Disease Progression; Genetic Vectors; Humans; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Receptors, G-Protein-Coupled; Time Factors; Transduction, Genetic; Up-Regulation	2008
Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. The Journal of clinical investigation, 1995, Volume: 96, Issue:2 Topics: Angiotensin II; Animals; Base Sequence; Disease Progression; Endothelium, Vascular; Extracellular Matrix Proteins; Gene Expression Regulation; Glomerulosclerosis, Focal Segmental; Hypertrophy; Kidney Glomerulus; Male; Molecular Sequence Data; Nephrectomy; Rats; Rats, Wistar; Renal Circulation; RNA, Messenger; Transforming Growth Factor beta	1995
Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells. Life sciences, 1995, Volume: 56, Issue:20 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Aorta; Arteriosclerosis; Biphenyl Compounds; Cell Division; Cells, Cultured; Disease Progression; DNA; Humans; Imidazoles; Kinetics; Losartan; Muscle, Smooth, Vascular; Receptors, Angiotensin; Renin-Angiotensin System; Stimulation, Chemical; Tetrazoles; Thymidine; Tritium	1995
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathy. American journal of hypertension, 1997, Volume: 10, Issue:3 Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Kidney; Nephrectomy; Pyrimidines; Rats; Rats, Wistar; Tetrazoles	1997
Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats. Kidney international. Supplement, 1997, Volume: 63 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Progression; Enalapril; Fibrosis; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Kidney Failure, Chronic; Male; Nephrectomy; Proteinuria; Rats; Rats, Sprague-Dawley; Tetrazoles; Transforming Growth Factor beta	1997
Endothelin-1 expression in hearts of transgenic hypertensive mice overexpressing angiotensin II. Journal of cardiovascular pharmacology, 1998, Volume: 31 Suppl 1 Topics: Angiotensin II; Animals; Cardiomegaly; Disease Progression; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Humans; Hypertension; Indans; Male; Mice; Mice, Transgenic; Myocardium; Polymerase Chain Reaction; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger	1998
Role of angiotensin II, endothelin-1, and nitric oxide in HgCl2-induced acute renal failure. Toxicology and applied pharmacology, 1998, Volume: 152, Issue:2 Topics: Acute Kidney Injury; Angiotensin II; Animals; Blood Urea Nitrogen; Chromium; Creatinine; Disease Progression; Endothelin-1; Female; Immunohistochemistry; Kidney Tubules; Mercuric Chloride; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Tumor Necrosis Factor-alpha	1998
Insertion/deletion angiotensin converting enzyme gene polymorphism affects the microvascular structure of the kidney in patients with nondiabetic renal disease. Journal of hypertension, 1999, Volume: 17, Issue:3 Topics: Adult; Angiotensin I; Angiotensin II; Biopsy; Disease Progression; DNA; DNA Primers; Female; Follow-Up Studies; Gene Deletion; Genotype; Humans; Kidney Diseases; Kidney Medulla; Male; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Genetic; Renal Artery; Renin	1999
Vascular alterations during the development and progression of experimental heart failure. Journal of cardiac failure, 1999, Volume: 5, Issue:1 Topics: Angiotensin II; Animals; Cricetinae; Disease Models, Animal; Disease Progression; Heart Failure; Male; Mesocricetus; Norepinephrine; Vasoconstriction; Vasoconstrictor Agents	1999
Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. The American journal of cardiology, 1999, Apr-15, Volume: 83, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Artery Disease; Disease Progression; Humans; Rats; Treatment Outcome	1999
Influence of angiotensin on the early progression of heart failure. American journal of physiology. Regulatory, integrative and comparative physiology, 2000, Volume: 278, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Proteins; Captopril; Cardiac Output, Low; Cardiac Pacing, Artificial; Disease Progression; Dogs; Electrolytes; Hematocrit; Hemodynamics; Male; Neurotransmitter Agents; Renal Circulation; Sodium Chloride; Water-Electrolyte Balance	2000
Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. Gastroenterology, 2000, Volume: 118, Issue:3 Topics: Adult; Angiotensin II; Antihypertensive Agents; Blood Vessels; Disease Progression; Dose-Response Relationship, Drug; Female; Forearm; Hemodynamics; Humans; Liver Cirrhosis; Losartan; Lower Body Negative Pressure; Male; Middle Aged; Norepinephrine; Regional Blood Flow; Sympathetic Nervous System; Vasoconstrictor Agents; Vasomotor System	2000
Contribution of angiotensin II to late renal injury after acute ischemia. Journal of the American Society of Nephrology : JASN, 2000, Volume: 11, Issue:7 Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Progression; Enalapril; Ischemia; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley; Renal Circulation; Time Factors	2000
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney international, 2000, Volume: 58, Issue:3 Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Blotting, Northern; Creatinine; Disease Progression; Fibrosis; Gene Expression; Glomerulosclerosis, Focal Segmental; In Situ Hybridization; Kidney Glomerulus; Male; Mineralocorticoid Receptor Antagonists; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spironolactone	2000
Minimizing the progression of kidney disease. Introduction. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:3 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetic Angiopathies; Disease Progression; Diuretics; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Patient Care Planning; Renin-Angiotensin System	2000
How renal cytokines and growth factors contribute to renal disease progression. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 37, Issue:1 Suppl 2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cytokines; Disease Progression; Glomerular Filtration Rate; Growth Substances; Humans; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Proteinuria; Rats	2001
Insulin-like growth factor-binding protein-3 induces fetalization in neonatal rat cardiomyocytes. DNA and cell biology, 2000, Volume: 19, Issue:12 Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Cultured; Coronary Vessels; Disease Models, Animal; Disease Progression; Endothelin-1; Gene Expression Profiling; Gene Expression Regulation; Heart Ventricles; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Myocardial Infarction; Myocardium; Myosin Heavy Chains; Nonmuscle Myosin Type IIB; Oligonucleotide Array Sequence Analysis; Rats; RNA, Messenger; Transforming Growth Factor beta; Troponin I	2000
Involvement of angiotensin II in progression of renal injury in rats with genetic non-insulin-dependent diabetes mellitus (Wistar fatty rats). Japanese journal of pharmacology, 2001, Volume: 85, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Disease Progression; Enalapril; Glomerular Mesangium; Male; Proteins; Proteinuria; Rats; Rats, Wistar; Rats, Zucker; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Triglycerides	2001
Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure. Circulation, 2001, Jul-31, Volume: 104, Issue:5 Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Disease Progression; Endothelin-1; Endothelins; Gene Expression Regulation; Heart Failure; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Male; Organ Size; Peptidyl-Dipeptidase A; Protein Precursors; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides; Survival Analysis; Thiazepines; Time Factors	2001